Sentence	entity_1	entity_2	entity_3	entity_4	entity_5	entity_6	entity_7	entity_8	entity_9	json	split
METHODS: Using flow cytometry we evaluated 18 human lung cancer cell lines for the expression of different surface markers on lung cancers suggested to be possible prognostic parameters, including epidermal growth factor receptor ( EGFR), intercellular adhesion molecule 1 ( ICAM - 1), Fas and CD40.	human,46,51,Organism	lung cancer cell lines,52,74,Cell	lung cancers,126,138,Cancer	epidermal growth factor receptor,197,229,Gene_or_gene_product	EGFR,232,236,Gene_or_gene_product	intercellular adhesion molecule 1,239,272,Gene_or_gene_product	ICAM - 1,275,283,Gene_or_gene_product	Fas,286,289,Gene_or_gene_product	CD40,294,298,Gene_or_gene_product	"[{""token"": ""human"", ""start_span"": 46, ""end_span"": 51, ""type"": ""Organism""}, {""token"": ""lung cancer cell lines"", ""start_span"": 52, ""end_span"": 74, ""type"": ""Cell""}, {""token"": ""lung cancers"", ""start_span"": 126, ""end_span"": 138, ""type"": ""Cancer""}, {""token"": ""epidermal growth factor receptor"", ""start_span"": 197, ""end_span"": 229, ""type"": ""Gene_or_gene_product""}, {""token"": ""EGFR"", ""start_span"": 232, ""end_span"": 236, ""type"": ""Gene_or_gene_product""}, {""token"": ""intercellular adhesion molecule 1"", ""start_span"": 239, ""end_span"": 272, ""type"": ""Gene_or_gene_product""}, {""token"": ""ICAM - 1"", ""start_span"": 275, ""end_span"": 283, ""type"": ""Gene_or_gene_product""}, {""token"": ""Fas"", ""start_span"": 286, ""end_span"": 289, ""type"": ""Gene_or_gene_product""}, {""token"": ""CD40"", ""start_span"": 294, ""end_span"": 298, ""type"": ""Gene_or_gene_product""}]"	train
Patients with liver and / or bone metastases had significantly higher median concentrations of S - 100beta, IL - 6 and IL - 10 than those with only skin, nodal and / or lung involvement.	Patients,0,8,Organism	liver,14,19,Organ	bone,29,33,Organ	S - 100beta,95,106,Gene_or_gene_product	IL - 6,108,114,Gene_or_gene_product	IL - 10,119,126,Gene_or_gene_product	skin,148,152,Organ	nodal,154,159,Multi	lung,169,173,Organ	"[{""token"": ""Patients"", ""start_span"": 0, ""end_span"": 8, ""type"": ""Organism""}, {""token"": ""liver"", ""start_span"": 14, ""end_span"": 19, ""type"": ""Organ""}, {""token"": ""bone"", ""start_span"": 29, ""end_span"": 33, ""type"": ""Organ""}, {""token"": ""S - 100beta"", ""start_span"": 95, ""end_span"": 106, ""type"": ""Gene_or_gene_product""}, {""token"": ""IL - 6"", ""start_span"": 108, ""end_span"": 114, ""type"": ""Gene_or_gene_product""}, {""token"": ""IL - 10"", ""start_span"": 119, ""end_span"": 126, ""type"": ""Gene_or_gene_product""}, {""token"": ""skin"", ""start_span"": 148, ""end_span"": 152, ""type"": ""Organ""}, {""token"": ""nodal"", ""start_span"": 154, ""end_span"": 159, ""type"": ""Multi""}, {""token"": ""lung"", ""start_span"": 169, ""end_span"": 173, ""type"": ""Organ""}]"	train
The therapeutic options available in this regard include measures that: down - regulate serum free IGF - I; suppress the synthesis of mevalonic acid and / or certain derivatives thereof; modulate arachidonate metabolism by inhibiting 5 - lipoxygenase, 12 - lipoxygenase, or COX - 2; antagonize the activation of AP - 1 transcription factors; promote the activation of PPAR - gamma transcription factors; and that suppress angiogenesis by additional mechanisms.	serum,88,93,Organism_substance	IGF - I,99,106,Gene_or_gene_product	mevalonic acid,134,148,Chemical	arachidonate,196,208,Chemical	5 - lipoxygenase,234,250,Gene_or_gene_product	12 - lipoxygenase,252,269,Gene_or_gene_product	COX - 2,274,281,Gene_or_gene_product	AP - 1,312,318,Gene_or_gene_product	PPAR - gamma,368,380,Gene_or_gene_product	"[{""token"": ""serum"", ""start_span"": 88, ""end_span"": 93, ""type"": ""Organism_substance""}, {""token"": ""IGF - I"", ""start_span"": 99, ""end_span"": 106, ""type"": ""Gene_or_gene_product""}, {""token"": ""mevalonic acid"", ""start_span"": 134, ""end_span"": 148, ""type"": ""Chemical""}, {""token"": ""arachidonate"", ""start_span"": 196, ""end_span"": 208, ""type"": ""Chemical""}, {""token"": ""5 - lipoxygenase"", ""start_span"": 234, ""end_span"": 250, ""type"": ""Gene_or_gene_product""}, {""token"": ""12 - lipoxygenase"", ""start_span"": 252, ""end_span"": 269, ""type"": ""Gene_or_gene_product""}, {""token"": ""COX - 2"", ""start_span"": 274, ""end_span"": 281, ""type"": ""Gene_or_gene_product""}, {""token"": ""AP - 1"", ""start_span"": 312, ""end_span"": 318, ""type"": ""Gene_or_gene_product""}, {""token"": ""PPAR - gamma"", ""start_span"": 368, ""end_span"": 380, ""type"": ""Gene_or_gene_product""}]"	train
Treatment of REF or REF expressing full - length T antigen, an N - terminal segment, or T251 - 708 resulted in increased expression of the p53 - responsive MDM2 gene; apoptosis occurred through a p53 - dependent pathway, as p53 - null cells expressing these T antigens were resistant to 5 - FU - induced apoptosis.	REF,13,16,Cell	REF,20,23,Cell	T antigen,49,58,Gene_or_gene_product	p53,139,142,Gene_or_gene_product	MDM2,156,160,Gene_or_gene_product	p53,196,199,Gene_or_gene_product	p53,224,227,Gene_or_gene_product	T antigens,258,268,Gene_or_gene_product	5 - FU,287,293,Chemical	"[{""token"": ""REF"", ""start_span"": 13, ""end_span"": 16, ""type"": ""Cell""}, {""token"": ""REF"", ""start_span"": 20, ""end_span"": 23, ""type"": ""Cell""}, {""token"": ""T antigen"", ""start_span"": 49, ""end_span"": 58, ""type"": ""Gene_or_gene_product""}, {""token"": ""p53"", ""start_span"": 139, ""end_span"": 142, ""type"": ""Gene_or_gene_product""}, {""token"": ""MDM2"", ""start_span"": 156, ""end_span"": 160, ""type"": ""Gene_or_gene_product""}, {""token"": ""p53"", ""start_span"": 196, ""end_span"": 199, ""type"": ""Gene_or_gene_product""}, {""token"": ""p53"", ""start_span"": 224, ""end_span"": 227, ""type"": ""Gene_or_gene_product""}, {""token"": ""T antigens"", ""start_span"": 258, ""end_span"": 268, ""type"": ""Gene_or_gene_product""}, {""token"": ""5 - FU"", ""start_span"": 287, ""end_span"": 293, ""type"": ""Chemical""}]"	train
Because there is little information on the expression of topo I in colorectal tumors, this study evaluated and characterized topo I protein expression in primary colorectal cancer and lymph node metastases and studied the association between topo I protein expression and clinicopathologic data, p53 status, and proliferating cell nuclear antigen ( PCNA) status.	topo I,57,63,Gene_or_gene_product	colorectal tumors,67,84,Cancer	topo I,125,131,Gene_or_gene_product	colorectal cancer,162,179,Cancer	lymph node metastases,184,205,Cancer	topo I,242,248,Gene_or_gene_product	p53,296,299,Gene_or_gene_product	proliferating cell nuclear antigen,312,346,Gene_or_gene_product	PCNA,349,353,Gene_or_gene_product	"[{""token"": ""topo I"", ""start_span"": 57, ""end_span"": 63, ""type"": ""Gene_or_gene_product""}, {""token"": ""colorectal tumors"", ""start_span"": 67, ""end_span"": 84, ""type"": ""Cancer""}, {""token"": ""topo I"", ""start_span"": 125, ""end_span"": 131, ""type"": ""Gene_or_gene_product""}, {""token"": ""colorectal cancer"", ""start_span"": 162, ""end_span"": 179, ""type"": ""Cancer""}, {""token"": ""lymph node metastases"", ""start_span"": 184, ""end_span"": 205, ""type"": ""Cancer""}, {""token"": ""topo I"", ""start_span"": 242, ""end_span"": 248, ""type"": ""Gene_or_gene_product""}, {""token"": ""p53"", ""start_span"": 296, ""end_span"": 299, ""type"": ""Gene_or_gene_product""}, {""token"": ""proliferating cell nuclear antigen"", ""start_span"": 312, ""end_span"": 346, ""type"": ""Gene_or_gene_product""}, {""token"": ""PCNA"", ""start_span"": 349, ""end_span"": 353, ""type"": ""Gene_or_gene_product""}]"	train
METHODS: Expression of MMP - 9 was studied in human NPC cell lines cultured in vitro: CNE1 ( well differentiated cell line of NPC) and CNE1 - GL ( CNE1 cell line transfected with an eukaryotic LMP1 - expression plasmid) by SP immunohistochemistry and Western blot analysis.	MMP - 9,23,30,Gene_or_gene_product	human,46,51,Organism	NPC cell lines,52,66,Cell	CNE1,86,90,Cell	cell line,113,122,Cell	NPC,126,129,Cell	CNE1 - GL,135,144,Cell	CNE1 cell line,147,161,Cell	LMP1,193,197,Gene_or_gene_product	"[{""token"": ""MMP - 9"", ""start_span"": 23, ""end_span"": 30, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 46, ""end_span"": 51, ""type"": ""Organism""}, {""token"": ""NPC cell lines"", ""start_span"": 52, ""end_span"": 66, ""type"": ""Cell""}, {""token"": ""CNE1"", ""start_span"": 86, ""end_span"": 90, ""type"": ""Cell""}, {""token"": ""cell line"", ""start_span"": 113, ""end_span"": 122, ""type"": ""Cell""}, {""token"": ""NPC"", ""start_span"": 126, ""end_span"": 129, ""type"": ""Cell""}, {""token"": ""CNE1 - GL"", ""start_span"": 135, ""end_span"": 144, ""type"": ""Cell""}, {""token"": ""CNE1 cell line"", ""start_span"": 147, ""end_span"": 161, ""type"": ""Cell""}, {""token"": ""LMP1"", ""start_span"": 193, ""end_span"": 197, ""type"": ""Gene_or_gene_product""}]"	train
Cell death induced by survivin targeting exhibited the hallmarks of mitochondrial - dependent apoptosis with release of cytochrome c and loss of mitochondrial transmembrane potential and was suppressed in Apaf - 1 or caspase - 9 knockout mouse embryonic fibroblasts.	Cell,0,4,Cell	survivin,22,30,Gene_or_gene_product	mitochondrial,68,81,Cellular_component	cytochrome c,120,132,Gene_or_gene_product	mitochondrial,145,158,Cellular_component	Apaf - 1,205,213,Gene_or_gene_product	caspase - 9,217,228,Gene_or_gene_product	mouse,238,243,Organism	embryonic fibroblasts,244,265,Cell	"[{""token"": ""Cell"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Cell""}, {""token"": ""survivin"", ""start_span"": 22, ""end_span"": 30, ""type"": ""Gene_or_gene_product""}, {""token"": ""mitochondrial"", ""start_span"": 68, ""end_span"": 81, ""type"": ""Cellular_component""}, {""token"": ""cytochrome c"", ""start_span"": 120, ""end_span"": 132, ""type"": ""Gene_or_gene_product""}, {""token"": ""mitochondrial"", ""start_span"": 145, ""end_span"": 158, ""type"": ""Cellular_component""}, {""token"": ""Apaf - 1"", ""start_span"": 205, ""end_span"": 213, ""type"": ""Gene_or_gene_product""}, {""token"": ""caspase - 9"", ""start_span"": 217, ""end_span"": 228, ""type"": ""Gene_or_gene_product""}, {""token"": ""mouse"", ""start_span"": 238, ""end_span"": 243, ""type"": ""Organism""}, {""token"": ""embryonic fibroblasts"", ""start_span"": 244, ""end_span"": 265, ""type"": ""Cell""}]"	train
In order to elucidate a mechanism for cancer - induced osteoclastogenesis, cells from a human breast cancer line, MDA - MB - 231, were directly co - cultured with ST2, MC3T3 - E1, or with primary mouse calvarial cells.	cancer,38,44,Cancer	cells,75,80,Cell	human,88,93,Organism	breast cancer,94,107,Cancer	MDA - MB - 231,114,128,Cell	ST2,163,166,Cell	MC3T3 - E1,168,178,Cell	mouse,196,201,Organism	calvarial cells,202,217,Cell	"[{""token"": ""cancer"", ""start_span"": 38, ""end_span"": 44, ""type"": ""Cancer""}, {""token"": ""cells"", ""start_span"": 75, ""end_span"": 80, ""type"": ""Cell""}, {""token"": ""human"", ""start_span"": 88, ""end_span"": 93, ""type"": ""Organism""}, {""token"": ""breast cancer"", ""start_span"": 94, ""end_span"": 107, ""type"": ""Cancer""}, {""token"": ""MDA - MB - 231"", ""start_span"": 114, ""end_span"": 128, ""type"": ""Cell""}, {""token"": ""ST2"", ""start_span"": 163, ""end_span"": 166, ""type"": ""Cell""}, {""token"": ""MC3T3 - E1"", ""start_span"": 168, ""end_span"": 178, ""type"": ""Cell""}, {""token"": ""mouse"", ""start_span"": 196, ""end_span"": 201, ""type"": ""Organism""}, {""token"": ""calvarial cells"", ""start_span"": 202, ""end_span"": 217, ""type"": ""Cell""}]"	train
After removal of fibroblasts by exposure to G - 418, the tumor cells exhibited increased metastatic ability and human K - ras oncogene mRNA, suggesting an intimate interaction between H - 3 cells and fibroblasts influencing the function of transfected human K - ras oncogene.	fibroblasts,17,28,Cell	G - 418,44,51,Chemical	tumor cells,57,68,Cell	human,112,117,Organism	K - ras,118,125,Gene_or_gene_product	H - 3 cells,184,195,Cell	fibroblasts,200,211,Cell	human,252,257,Organism	K - ras,258,265,Gene_or_gene_product	"[{""token"": ""fibroblasts"", ""start_span"": 17, ""end_span"": 28, ""type"": ""Cell""}, {""token"": ""G - 418"", ""start_span"": 44, ""end_span"": 51, ""type"": ""Chemical""}, {""token"": ""tumor cells"", ""start_span"": 57, ""end_span"": 68, ""type"": ""Cell""}, {""token"": ""human"", ""start_span"": 112, ""end_span"": 117, ""type"": ""Organism""}, {""token"": ""K - ras"", ""start_span"": 118, ""end_span"": 125, ""type"": ""Gene_or_gene_product""}, {""token"": ""H - 3 cells"", ""start_span"": 184, ""end_span"": 195, ""type"": ""Cell""}, {""token"": ""fibroblasts"", ""start_span"": 200, ""end_span"": 211, ""type"": ""Cell""}, {""token"": ""human"", ""start_span"": 252, ""end_span"": 257, ""type"": ""Organism""}, {""token"": ""K - ras"", ""start_span"": 258, ""end_span"": 265, ""type"": ""Gene_or_gene_product""}]"	train
One week later, IGF - 1 - transfected SMCs had increased myocardial IGF - 1 and VEGF levels, increased Bcl2 expression, limited cell apoptosis, and enhanced vessel formation in the myocardial scar compared with the two control groups ( P less than 0. 05 for all groups).	IGF - 1,16,23,Gene_or_gene_product	SMCs,38,42,Cell	myocardial,57,67,Multi	IGF - 1,68,75,Gene_or_gene_product	VEGF,80,84,Gene_or_gene_product	Bcl2,103,107,Gene_or_gene_product	cell,128,132,Cell	vessel,157,163,Multi	myocardial scar,181,196,Pathological_formation	"[{""token"": ""IGF - 1"", ""start_span"": 16, ""end_span"": 23, ""type"": ""Gene_or_gene_product""}, {""token"": ""SMCs"", ""start_span"": 38, ""end_span"": 42, ""type"": ""Cell""}, {""token"": ""myocardial"", ""start_span"": 57, ""end_span"": 67, ""type"": ""Multi""}, {""token"": ""IGF - 1"", ""start_span"": 68, ""end_span"": 75, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 80, ""end_span"": 84, ""type"": ""Gene_or_gene_product""}, {""token"": ""Bcl2"", ""start_span"": 103, ""end_span"": 107, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell"", ""start_span"": 128, ""end_span"": 132, ""type"": ""Cell""}, {""token"": ""vessel"", ""start_span"": 157, ""end_span"": 163, ""type"": ""Multi""}, {""token"": ""myocardial scar"", ""start_span"": 181, ""end_span"": 196, ""type"": ""Pathological_formation""}]"	train
Hence, GM - CSF and IL - 3 enhance the intracellular metabolism of ara - C and its incorporation into the DNA of leukemic cells leading to a higher antileukemic activity of ara - C on clonogenic leukemic cells ( CFU - L).	GM - CSF,7,15,Gene_or_gene_product	IL - 3,20,26,Gene_or_gene_product	intracellular,39,52,Immaterial_anatomical_entity	ara - C,67,74,Chemical	DNA,106,109,Cellular_component	leukemic cells,113,127,Cell	ara - C,173,180,Chemical	clonogenic leukemic cells,184,209,Cell	CFU - L,212,219,Cell	"[{""token"": ""GM - CSF"", ""start_span"": 7, ""end_span"": 15, ""type"": ""Gene_or_gene_product""}, {""token"": ""IL - 3"", ""start_span"": 20, ""end_span"": 26, ""type"": ""Gene_or_gene_product""}, {""token"": ""intracellular"", ""start_span"": 39, ""end_span"": 52, ""type"": ""Immaterial_anatomical_entity""}, {""token"": ""ara - C"", ""start_span"": 67, ""end_span"": 74, ""type"": ""Chemical""}, {""token"": ""DNA"", ""start_span"": 106, ""end_span"": 109, ""type"": ""Cellular_component""}, {""token"": ""leukemic cells"", ""start_span"": 113, ""end_span"": 127, ""type"": ""Cell""}, {""token"": ""ara - C"", ""start_span"": 173, ""end_span"": 180, ""type"": ""Chemical""}, {""token"": ""clonogenic leukemic cells"", ""start_span"": 184, ""end_span"": 209, ""type"": ""Cell""}, {""token"": ""CFU - L"", ""start_span"": 212, ""end_span"": 219, ""type"": ""Cell""}]"	train
In addition to p16 ( INK4A), the INK4A locus encodes a splice variant, termed p12 - - specifically expressed in human pancreas - - and ARF, a protein encoded by an alternative reading frame that acts as a tumor suppressor through the p53 pathway.	p16,15,18,Gene_or_gene_product	INK4A,21,26,Gene_or_gene_product	INK4A,33,38,Gene_or_gene_product	p12,78,81,Gene_or_gene_product	human,112,117,Organism	pancreas,118,126,Organ	ARF,135,138,Gene_or_gene_product	tumor,205,210,Cancer	p53,234,237,Gene_or_gene_product	"[{""token"": ""p16"", ""start_span"": 15, ""end_span"": 18, ""type"": ""Gene_or_gene_product""}, {""token"": ""INK4A"", ""start_span"": 21, ""end_span"": 26, ""type"": ""Gene_or_gene_product""}, {""token"": ""INK4A"", ""start_span"": 33, ""end_span"": 38, ""type"": ""Gene_or_gene_product""}, {""token"": ""p12"", ""start_span"": 78, ""end_span"": 81, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 112, ""end_span"": 117, ""type"": ""Organism""}, {""token"": ""pancreas"", ""start_span"": 118, ""end_span"": 126, ""type"": ""Organ""}, {""token"": ""ARF"", ""start_span"": 135, ""end_span"": 138, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 205, ""end_span"": 210, ""type"": ""Cancer""}, {""token"": ""p53"", ""start_span"": 234, ""end_span"": 237, ""type"": ""Gene_or_gene_product""}]"	train
To better understand the intracellular signaling pathways, we examined the effect of HKa on the phosphorylation of Akt and its downstream effector, GSK - 3alpha HKa and D5 inhibit phosphorylation of Akt and GSK - 3alpha after stimulation withVEGF and S1P.	intracellular,25,38,Immaterial_anatomical_entity	HKa,85,88,Gene_or_gene_product	Akt,115,118,Gene_or_gene_product	GSK - 3alpha,148,160,Gene_or_gene_product	HKa,161,164,Gene_or_gene_product	Akt,199,202,Gene_or_gene_product	GSK - 3alpha,207,219,Gene_or_gene_product	withVEGF,238,246,Gene_or_gene_product	S1P,251,254,Gene_or_gene_product	"[{""token"": ""intracellular"", ""start_span"": 25, ""end_span"": 38, ""type"": ""Immaterial_anatomical_entity""}, {""token"": ""HKa"", ""start_span"": 85, ""end_span"": 88, ""type"": ""Gene_or_gene_product""}, {""token"": ""Akt"", ""start_span"": 115, ""end_span"": 118, ""type"": ""Gene_or_gene_product""}, {""token"": ""GSK - 3alpha"", ""start_span"": 148, ""end_span"": 160, ""type"": ""Gene_or_gene_product""}, {""token"": ""HKa"", ""start_span"": 161, ""end_span"": 164, ""type"": ""Gene_or_gene_product""}, {""token"": ""Akt"", ""start_span"": 199, ""end_span"": 202, ""type"": ""Gene_or_gene_product""}, {""token"": ""GSK - 3alpha"", ""start_span"": 207, ""end_span"": 219, ""type"": ""Gene_or_gene_product""}, {""token"": ""withVEGF"", ""start_span"": 238, ""end_span"": 246, ""type"": ""Gene_or_gene_product""}, {""token"": ""S1P"", ""start_span"": 251, ""end_span"": 254, ""type"": ""Gene_or_gene_product""}]"	train
p63 also correlated with advanced pathological stage, tumor size, and the expression of human telomerase reverse transcriptase ( hTERT), tissue inhibitor of matrix metalloproteinase 1 ( TIMP1) and vascular endothelial growth factor ( VEGF).	p63,0,3,Gene_or_gene_product	tumor,54,59,Cancer	human,88,93,Organism	telomerase reverse transcriptase,94,126,Gene_or_gene_product	hTERT,129,134,Gene_or_gene_product	tissue inhibitor of matrix metalloproteinase 1,137,183,Gene_or_gene_product	TIMP1,186,191,Gene_or_gene_product	vascular endothelial growth factor,197,231,Gene_or_gene_product	VEGF,234,238,Gene_or_gene_product	"[{""token"": ""p63"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 54, ""end_span"": 59, ""type"": ""Cancer""}, {""token"": ""human"", ""start_span"": 88, ""end_span"": 93, ""type"": ""Organism""}, {""token"": ""telomerase reverse transcriptase"", ""start_span"": 94, ""end_span"": 126, ""type"": ""Gene_or_gene_product""}, {""token"": ""hTERT"", ""start_span"": 129, ""end_span"": 134, ""type"": ""Gene_or_gene_product""}, {""token"": ""tissue inhibitor of matrix metalloproteinase 1"", ""start_span"": 137, ""end_span"": 183, ""type"": ""Gene_or_gene_product""}, {""token"": ""TIMP1"", ""start_span"": 186, ""end_span"": 191, ""type"": ""Gene_or_gene_product""}, {""token"": ""vascular endothelial growth factor"", ""start_span"": 197, ""end_span"": 231, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 234, ""end_span"": 238, ""type"": ""Gene_or_gene_product""}]"	train
To elucidate the role of free radicals and leukocytes in MTX - induced oxidative organ damage and the putative protective effect of L - carnitine ( L - Car), Wistar albino rats were administered a single dose of MTX ( 20 mg / kg) followed by either saline or L - Car ( 500 mg / kg) for 5 days.	leukocytes,43,53,Cell	MTX,57,60,Chemical	organ,81,86,Organ	L - carnitine,132,145,Chemical	L - Car,148,155,Chemical	Wistar albino rats,158,176,Organism	MTX,212,215,Chemical	saline,249,255,Chemical	L - Car,259,266,Chemical	"[{""token"": ""leukocytes"", ""start_span"": 43, ""end_span"": 53, ""type"": ""Cell""}, {""token"": ""MTX"", ""start_span"": 57, ""end_span"": 60, ""type"": ""Chemical""}, {""token"": ""organ"", ""start_span"": 81, ""end_span"": 86, ""type"": ""Organ""}, {""token"": ""L - carnitine"", ""start_span"": 132, ""end_span"": 145, ""type"": ""Chemical""}, {""token"": ""L - Car"", ""start_span"": 148, ""end_span"": 155, ""type"": ""Chemical""}, {""token"": ""Wistar albino rats"", ""start_span"": 158, ""end_span"": 176, ""type"": ""Organism""}, {""token"": ""MTX"", ""start_span"": 212, ""end_span"": 215, ""type"": ""Chemical""}, {""token"": ""saline"", ""start_span"": 249, ""end_span"": 255, ""type"": ""Chemical""}, {""token"": ""L - Car"", ""start_span"": 259, ""end_span"": 266, ""type"": ""Chemical""}]"	train
To determine how p18 and p27 genetically interact with Men1, the tumor suppressor gene mutated in familial MEN1, we characterized p18 - Men1 and p27 - Men1 double mutant mice.	p18,17,20,Gene_or_gene_product	p27,25,28,Gene_or_gene_product	Men1,55,59,Gene_or_gene_product	tumor,65,70,Cancer	MEN1,107,111,Cancer	p18,130,133,Gene_or_gene_product	Men1,136,140,Gene_or_gene_product	p27,145,148,Gene_or_gene_product	Men1,151,155,Gene_or_gene_product	"[{""token"": ""p18"", ""start_span"": 17, ""end_span"": 20, ""type"": ""Gene_or_gene_product""}, {""token"": ""p27"", ""start_span"": 25, ""end_span"": 28, ""type"": ""Gene_or_gene_product""}, {""token"": ""Men1"", ""start_span"": 55, ""end_span"": 59, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 65, ""end_span"": 70, ""type"": ""Cancer""}, {""token"": ""MEN1"", ""start_span"": 107, ""end_span"": 111, ""type"": ""Cancer""}, {""token"": ""p18"", ""start_span"": 130, ""end_span"": 133, ""type"": ""Gene_or_gene_product""}, {""token"": ""Men1"", ""start_span"": 136, ""end_span"": 140, ""type"": ""Gene_or_gene_product""}, {""token"": ""p27"", ""start_span"": 145, ""end_span"": 148, ""type"": ""Gene_or_gene_product""}, {""token"": ""Men1"", ""start_span"": 151, ""end_span"": 155, ""type"": ""Gene_or_gene_product""}]"	train
In the pituitary and pancreatic islets, phosphorylation of the retinoblastoma ( Rb) protein at both CDK2 and CDK4 / 6 sites was increased in p18 ( - / -) and Men1 ( + / -) cells and was further increased in p18 ( - / -); Men1 ( + / -) cells.	pituitary,7,16,Multi	pancreatic islets,21,38,Multi	retinoblastoma,63,77,Gene_or_gene_product	Rb,80,82,Gene_or_gene_product	CDK2,100,104,Gene_or_gene_product	CDK4 / 6,109,117,Gene_or_gene_product	Men1,158,162,Gene_or_gene_product	p18,207,210,Gene_or_gene_product	Men1,221,225,Gene_or_gene_product	"[{""token"": ""pituitary"", ""start_span"": 7, ""end_span"": 16, ""type"": ""Multi""}, {""token"": ""pancreatic islets"", ""start_span"": 21, ""end_span"": 38, ""type"": ""Multi""}, {""token"": ""retinoblastoma"", ""start_span"": 63, ""end_span"": 77, ""type"": ""Gene_or_gene_product""}, {""token"": ""Rb"", ""start_span"": 80, ""end_span"": 82, ""type"": ""Gene_or_gene_product""}, {""token"": ""CDK2"", ""start_span"": 100, ""end_span"": 104, ""type"": ""Gene_or_gene_product""}, {""token"": ""CDK4 / 6"", ""start_span"": 109, ""end_span"": 117, ""type"": ""Gene_or_gene_product""}, {""token"": ""Men1"", ""start_span"": 158, ""end_span"": 162, ""type"": ""Gene_or_gene_product""}, {""token"": ""p18"", ""start_span"": 207, ""end_span"": 210, ""type"": ""Gene_or_gene_product""}, {""token"": ""Men1"", ""start_span"": 221, ""end_span"": 225, ""type"": ""Gene_or_gene_product""}]"	train
The results show that, without affecting in vitro human PMN viability and chemokine - receptor expression, Hyp ( as stable dicyclohexylammonium salt) was able to inhibit in a dose - dependent manner their chemotaxis and chemoinvasion ( IC50 = 1 microM for both); this effect was associated with a reduced expression of the adhesion molecule CD11b by formyl - Met - Leu - Phe - stimulated neutrophils and block of LE - triggered activation of the gelatinase matrix metalloproteinase - 9.	human,50,55,Organism	PMN,56,59,Cell	Hyp,107,110,Chemical	dicyclohexylammonium salt,123,148,Chemical	CD11b,341,346,Gene_or_gene_product	formyl - Met - Leu - Phe,350,374,Chemical	neutrophils,388,399,Cell	LE,413,415,Gene_or_gene_product	gelatinase matrix metalloproteinase - 9,446,485,Gene_or_gene_product	"[{""token"": ""human"", ""start_span"": 50, ""end_span"": 55, ""type"": ""Organism""}, {""token"": ""PMN"", ""start_span"": 56, ""end_span"": 59, ""type"": ""Cell""}, {""token"": ""Hyp"", ""start_span"": 107, ""end_span"": 110, ""type"": ""Chemical""}, {""token"": ""dicyclohexylammonium salt"", ""start_span"": 123, ""end_span"": 148, ""type"": ""Chemical""}, {""token"": ""CD11b"", ""start_span"": 341, ""end_span"": 346, ""type"": ""Gene_or_gene_product""}, {""token"": ""formyl - Met - Leu - Phe"", ""start_span"": 350, ""end_span"": 374, ""type"": ""Chemical""}, {""token"": ""neutrophils"", ""start_span"": 388, ""end_span"": 399, ""type"": ""Cell""}, {""token"": ""LE"", ""start_span"": 413, ""end_span"": 415, ""type"": ""Gene_or_gene_product""}, {""token"": ""gelatinase matrix metalloproteinase - 9"", ""start_span"": 446, ""end_span"": 485, ""type"": ""Gene_or_gene_product""}]"	train
Statistically significant relationship between p53 expression in primary oral cancers and its expression in lymph node metastases ( P < 0. 02) as well as increased expression of Bcl - xL, Bax, and p53 in metastatic sites compared with primary tumors could indicate an association of these proteins with oral cancer progression and development of metastases.	p53,47,50,Gene_or_gene_product	oral,73,77,Organism_subdivision	cancers,78,85,Cancer	lymph node,108,118,Multi	Bcl - xL,178,186,Gene_or_gene_product	Bax,188,191,Gene_or_gene_product	p53,197,200,Gene_or_gene_product	tumors,243,249,Cancer	oral cancer,303,314,Cancer	"[{""token"": ""p53"", ""start_span"": 47, ""end_span"": 50, ""type"": ""Gene_or_gene_product""}, {""token"": ""oral"", ""start_span"": 73, ""end_span"": 77, ""type"": ""Organism_subdivision""}, {""token"": ""cancers"", ""start_span"": 78, ""end_span"": 85, ""type"": ""Cancer""}, {""token"": ""lymph node"", ""start_span"": 108, ""end_span"": 118, ""type"": ""Multi""}, {""token"": ""Bcl - xL"", ""start_span"": 178, ""end_span"": 186, ""type"": ""Gene_or_gene_product""}, {""token"": ""Bax"", ""start_span"": 188, ""end_span"": 191, ""type"": ""Gene_or_gene_product""}, {""token"": ""p53"", ""start_span"": 197, ""end_span"": 200, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumors"", ""start_span"": 243, ""end_span"": 249, ""type"": ""Cancer""}, {""token"": ""oral cancer"", ""start_span"": 303, ""end_span"": 314, ""type"": ""Cancer""}]"	train
Furthermore, there is strong evidence suggesting that aberrant activation of Wnt signaling induces mammary tumors from stem / progenitor cells, and that Wnt exerts its oncogenic effects through LRP5 / 6 - mediated activation of beta - catenin and mTOR pathways.	Wnt,77,80,Gene_or_gene_product	mammary tumors,99,113,Cancer	stem,119,123,Cell	progenitor cells,126,142,Cell	Wnt,153,156,Gene_or_gene_product	LRP5,194,198,Gene_or_gene_product	6,201,202,Gene_or_gene_product	beta - catenin,228,242,Gene_or_gene_product	mTOR,247,251,Gene_or_gene_product	"[{""token"": ""Wnt"", ""start_span"": 77, ""end_span"": 80, ""type"": ""Gene_or_gene_product""}, {""token"": ""mammary tumors"", ""start_span"": 99, ""end_span"": 113, ""type"": ""Cancer""}, {""token"": ""stem"", ""start_span"": 119, ""end_span"": 123, ""type"": ""Cell""}, {""token"": ""progenitor cells"", ""start_span"": 126, ""end_span"": 142, ""type"": ""Cell""}, {""token"": ""Wnt"", ""start_span"": 153, ""end_span"": 156, ""type"": ""Gene_or_gene_product""}, {""token"": ""LRP5"", ""start_span"": 194, ""end_span"": 198, ""type"": ""Gene_or_gene_product""}, {""token"": ""6"", ""start_span"": 201, ""end_span"": 202, ""type"": ""Gene_or_gene_product""}, {""token"": ""beta - catenin"", ""start_span"": 228, ""end_span"": 242, ""type"": ""Gene_or_gene_product""}, {""token"": ""mTOR"", ""start_span"": 247, ""end_span"": 251, ""type"": ""Gene_or_gene_product""}]"	train
RUNX1 DNA - binding mutations and RUNX1 - PRDM16 cryptic fusions in BCR - ABL + leukemias are frequently associated with secondary trisomy 21 and may contribute to clonal evolution and imatinib resistance.	RUNX1,0,5,Gene_or_gene_product	DNA,6,9,Cellular_component	RUNX1,34,39,Gene_or_gene_product	PRDM16,42,48,Gene_or_gene_product	BCR,68,71,Gene_or_gene_product	ABL,74,77,Gene_or_gene_product	21,139,141,Cellular_component	clonal,164,170,Cell	imatinib,185,193,Chemical	"[{""token"": ""RUNX1"", ""start_span"": 0, ""end_span"": 5, ""type"": ""Gene_or_gene_product""}, {""token"": ""DNA"", ""start_span"": 6, ""end_span"": 9, ""type"": ""Cellular_component""}, {""token"": ""RUNX1"", ""start_span"": 34, ""end_span"": 39, ""type"": ""Gene_or_gene_product""}, {""token"": ""PRDM16"", ""start_span"": 42, ""end_span"": 48, ""type"": ""Gene_or_gene_product""}, {""token"": ""BCR"", ""start_span"": 68, ""end_span"": 71, ""type"": ""Gene_or_gene_product""}, {""token"": ""ABL"", ""start_span"": 74, ""end_span"": 77, ""type"": ""Gene_or_gene_product""}, {""token"": ""21"", ""start_span"": 139, ""end_span"": 141, ""type"": ""Cellular_component""}, {""token"": ""clonal"", ""start_span"": 164, ""end_span"": 170, ""type"": ""Cell""}, {""token"": ""imatinib"", ""start_span"": 185, ""end_span"": 193, ""type"": ""Chemical""}]"	train
To identify a suitable donor cell population for gene therapy applications to the central nervous system, primary fibroblasts isolated from skin biopsies and maintained in culture are employed as autologous cells for intracerebral grafting within the adult rat striatum.	donor cell population,23,44,Cell	central nervous system,82,104,Anatomical_system	fibroblasts,114,125,Cell	skin biopsies,140,153,Multi	culture,172,179,Cell	cells,207,212,Cell	intracerebral,217,230,Immaterial_anatomical_entity	rat,257,260,Organism	striatum,261,269,Multi	"[{""token"": ""donor cell population"", ""start_span"": 23, ""end_span"": 44, ""type"": ""Cell""}, {""token"": ""central nervous system"", ""start_span"": 82, ""end_span"": 104, ""type"": ""Anatomical_system""}, {""token"": ""fibroblasts"", ""start_span"": 114, ""end_span"": 125, ""type"": ""Cell""}, {""token"": ""skin biopsies"", ""start_span"": 140, ""end_span"": 153, ""type"": ""Multi""}, {""token"": ""culture"", ""start_span"": 172, ""end_span"": 179, ""type"": ""Cell""}, {""token"": ""cells"", ""start_span"": 207, ""end_span"": 212, ""type"": ""Cell""}, {""token"": ""intracerebral"", ""start_span"": 217, ""end_span"": 230, ""type"": ""Immaterial_anatomical_entity""}, {""token"": ""rat"", ""start_span"": 257, ""end_span"": 260, ""type"": ""Organism""}, {""token"": ""striatum"", ""start_span"": 261, ""end_span"": 269, ""type"": ""Multi""}]"	train
Inhibition of p38 SAPK reduced CBP HAT activity and its recruitment to the SRF. MRTF - A complex, whereas enforced induction of p38 by upstream activators ( e. g. MKK3 and MKK6) enhanced both CBP HAT and CCN1 promoter activities.	p38 SAPK,14,22,Gene_or_gene_product	CBP HAT,31,38,Gene_or_gene_product	SRF,75,78,Gene_or_gene_product	MRTF - A,80,88,Gene_or_gene_product	p38,128,131,Gene_or_gene_product	MKK3,163,167,Gene_or_gene_product	MKK6,172,176,Gene_or_gene_product	CBP HAT,192,199,Gene_or_gene_product	CCN1,204,208,Gene_or_gene_product	"[{""token"": ""p38 SAPK"", ""start_span"": 14, ""end_span"": 22, ""type"": ""Gene_or_gene_product""}, {""token"": ""CBP HAT"", ""start_span"": 31, ""end_span"": 38, ""type"": ""Gene_or_gene_product""}, {""token"": ""SRF"", ""start_span"": 75, ""end_span"": 78, ""type"": ""Gene_or_gene_product""}, {""token"": ""MRTF - A"", ""start_span"": 80, ""end_span"": 88, ""type"": ""Gene_or_gene_product""}, {""token"": ""p38"", ""start_span"": 128, ""end_span"": 131, ""type"": ""Gene_or_gene_product""}, {""token"": ""MKK3"", ""start_span"": 163, ""end_span"": 167, ""type"": ""Gene_or_gene_product""}, {""token"": ""MKK6"", ""start_span"": 172, ""end_span"": 176, ""type"": ""Gene_or_gene_product""}, {""token"": ""CBP HAT"", ""start_span"": 192, ""end_span"": 199, ""type"": ""Gene_or_gene_product""}, {""token"": ""CCN1"", ""start_span"": 204, ""end_span"": 208, ""type"": ""Gene_or_gene_product""}]"	train
Nontumorigenic, immortalized keratinocytes cell line ( 3PC), papilloma ( MT1 / 2), and squamous cell carcinoma ( Ca3 / 7) cell lines were initially used to study the cell growth inhibition by DMI.	keratinocytes cell line,29,52,Cell	3PC,55,58,Cell	papilloma,61,70,Cell	MT1 / 2,73,80,Cell	squamous cell carcinoma,87,110,Cell	Ca3 / 7,113,120,Cell	cell lines,122,132,Cell	cell,166,170,Cell	DMI,192,195,Chemical	"[{""token"": ""keratinocytes cell line"", ""start_span"": 29, ""end_span"": 52, ""type"": ""Cell""}, {""token"": ""3PC"", ""start_span"": 55, ""end_span"": 58, ""type"": ""Cell""}, {""token"": ""papilloma"", ""start_span"": 61, ""end_span"": 70, ""type"": ""Cell""}, {""token"": ""MT1 / 2"", ""start_span"": 73, ""end_span"": 80, ""type"": ""Cell""}, {""token"": ""squamous cell carcinoma"", ""start_span"": 87, ""end_span"": 110, ""type"": ""Cell""}, {""token"": ""Ca3 / 7"", ""start_span"": 113, ""end_span"": 120, ""type"": ""Cell""}, {""token"": ""cell lines"", ""start_span"": 122, ""end_span"": 132, ""type"": ""Cell""}, {""token"": ""cell"", ""start_span"": 166, ""end_span"": 170, ""type"": ""Cell""}, {""token"": ""DMI"", ""start_span"": 192, ""end_span"": 195, ""type"": ""Chemical""}]"	train
Measurements of respiration, CO2 and lactate production, and changes in the levels of various key metabolites of the glycolytic sequence and tricarboxylic acid cycle were made on five lines of rodent ascites tumor cells ( two strains of Ehrlich ascites tumor cells, Krebs II carcinoma, AS - 30D carcinoma, and L1210 cells) incubated aerobically in the presence of uniformly labeled D - [ 14C] glucose.	CO2,29,32,Chemical	lactate,37,44,Chemical	tricarboxylic acid,141,159,Chemical	rodent,193,199,Organism	ascites tumor cells,200,219,Cell	Ehrlich ascites tumor cells,237,264,Cell	Krebs II carcinoma,266,284,Cell	AS - 30D carcinoma,286,304,Cell	L1210 cells,310,321,Cell	"[{""token"": ""CO2"", ""start_span"": 29, ""end_span"": 32, ""type"": ""Chemical""}, {""token"": ""lactate"", ""start_span"": 37, ""end_span"": 44, ""type"": ""Chemical""}, {""token"": ""tricarboxylic acid"", ""start_span"": 141, ""end_span"": 159, ""type"": ""Chemical""}, {""token"": ""rodent"", ""start_span"": 193, ""end_span"": 199, ""type"": ""Organism""}, {""token"": ""ascites tumor cells"", ""start_span"": 200, ""end_span"": 219, ""type"": ""Cell""}, {""token"": ""Ehrlich ascites tumor cells"", ""start_span"": 237, ""end_span"": 264, ""type"": ""Cell""}, {""token"": ""Krebs II carcinoma"", ""start_span"": 266, ""end_span"": 284, ""type"": ""Cell""}, {""token"": ""AS - 30D carcinoma"", ""start_span"": 286, ""end_span"": 304, ""type"": ""Cell""}, {""token"": ""L1210 cells"", ""start_span"": 310, ""end_span"": 321, ""type"": ""Cell""}]"	train
Class - 3 semaphorins, semaphorin - 3B ( SEMA3B) and semaphorin - 3F ( SEMA3F), illustrate their effects by forming a complex with neuropilins ( NP - 1 or NP - 2) and plexins.	Class - 3 semaphorins,0,21,Gene_or_gene_product	semaphorin - 3B,23,38,Gene_or_gene_product	SEMA3B,41,47,Gene_or_gene_product	semaphorin - 3F,53,68,Gene_or_gene_product	SEMA3F,71,77,Gene_or_gene_product	neuropilins,131,142,Gene_or_gene_product	NP - 1,145,151,Gene_or_gene_product	NP - 2,155,161,Gene_or_gene_product	plexins,167,174,Gene_or_gene_product	"[{""token"": ""Class - 3 semaphorins"", ""start_span"": 0, ""end_span"": 21, ""type"": ""Gene_or_gene_product""}, {""token"": ""semaphorin - 3B"", ""start_span"": 23, ""end_span"": 38, ""type"": ""Gene_or_gene_product""}, {""token"": ""SEMA3B"", ""start_span"": 41, ""end_span"": 47, ""type"": ""Gene_or_gene_product""}, {""token"": ""semaphorin - 3F"", ""start_span"": 53, ""end_span"": 68, ""type"": ""Gene_or_gene_product""}, {""token"": ""SEMA3F"", ""start_span"": 71, ""end_span"": 77, ""type"": ""Gene_or_gene_product""}, {""token"": ""neuropilins"", ""start_span"": 131, ""end_span"": 142, ""type"": ""Gene_or_gene_product""}, {""token"": ""NP - 1"", ""start_span"": 145, ""end_span"": 151, ""type"": ""Gene_or_gene_product""}, {""token"": ""NP - 2"", ""start_span"": 155, ""end_span"": 161, ""type"": ""Gene_or_gene_product""}, {""token"": ""plexins"", ""start_span"": 167, ""end_span"": 174, ""type"": ""Gene_or_gene_product""}]"	train
Available data indicate that the timing of telomerase activation may allow the distinction of two different lymphomagenetic models: ( i) an early activation of telomerase via exogenous regulators of hTERT, along with an increased lymphocyte growth and a subsequent selection of cells with increased transforming potential may characterize several virus - related lymphoid malignancies; ( ii) a progressive shortening of telomeres, leading to genetic instability which favors a subsequent activation of telomerase via endogenous regulators may occur in most virus - unrelated lymphoid tumors.	telomerase,43,53,Gene_or_gene_product	telomerase,160,170,Gene_or_gene_product	hTERT,199,204,Gene_or_gene_product	lymphocyte,230,240,Cell	cells,278,283,Cell	lymphoid malignancies,363,384,Pathological_formation	telomeres,420,429,Cellular_component	telomerase,502,512,Gene_or_gene_product	lymphoid tumors,575,590,Cancer	"[{""token"": ""telomerase"", ""start_span"": 43, ""end_span"": 53, ""type"": ""Gene_or_gene_product""}, {""token"": ""telomerase"", ""start_span"": 160, ""end_span"": 170, ""type"": ""Gene_or_gene_product""}, {""token"": ""hTERT"", ""start_span"": 199, ""end_span"": 204, ""type"": ""Gene_or_gene_product""}, {""token"": ""lymphocyte"", ""start_span"": 230, ""end_span"": 240, ""type"": ""Cell""}, {""token"": ""cells"", ""start_span"": 278, ""end_span"": 283, ""type"": ""Cell""}, {""token"": ""lymphoid malignancies"", ""start_span"": 363, ""end_span"": 384, ""type"": ""Pathological_formation""}, {""token"": ""telomeres"", ""start_span"": 420, ""end_span"": 429, ""type"": ""Cellular_component""}, {""token"": ""telomerase"", ""start_span"": 502, ""end_span"": 512, ""type"": ""Gene_or_gene_product""}, {""token"": ""lymphoid tumors"", ""start_span"": 575, ""end_span"": 590, ""type"": ""Cancer""}]"	train
While betulin exhibited only moderate anticancer activity in other human cancer cells such as hepatoma SK - HEP - 1 cells, prostate carcinoma PC - 3, and lung carcinoma NCI - H460, with IC ( 50) values ranging from 20 to 60 microg / mL, it showed minor growth inhibition in human erythroleukemia K562 cells ( IC ( 50) > 100 microg / mL).	betulin,6,13,Chemical	anticancer,38,48,Cancer	human,67,72,Organism	cancer cells,73,85,Cell	hepatoma SK - HEP - 1 cells,94,121,Cell	prostate carcinoma PC - 3,123,148,Cell	lung carcinoma NCI - H460,154,179,Cell	human,274,279,Organism	erythroleukemia K562 cells,280,306,Cell	"[{""token"": ""betulin"", ""start_span"": 6, ""end_span"": 13, ""type"": ""Chemical""}, {""token"": ""anticancer"", ""start_span"": 38, ""end_span"": 48, ""type"": ""Cancer""}, {""token"": ""human"", ""start_span"": 67, ""end_span"": 72, ""type"": ""Organism""}, {""token"": ""cancer cells"", ""start_span"": 73, ""end_span"": 85, ""type"": ""Cell""}, {""token"": ""hepatoma SK - HEP - 1 cells"", ""start_span"": 94, ""end_span"": 121, ""type"": ""Cell""}, {""token"": ""prostate carcinoma PC - 3"", ""start_span"": 123, ""end_span"": 148, ""type"": ""Cell""}, {""token"": ""lung carcinoma NCI - H460"", ""start_span"": 154, ""end_span"": 179, ""type"": ""Cell""}, {""token"": ""human"", ""start_span"": 274, ""end_span"": 279, ""type"": ""Organism""}, {""token"": ""erythroleukemia K562 cells"", ""start_span"": 280, ""end_span"": 306, ""type"": ""Cell""}]"	train
METHODOLOGY / PRINCIPAL FINDINGS: Examination of FOXO3a and phosphorylated - Akt ( P - Akt) expression in breast cancer tissue microarrays showed nuclear FOXO3a was associated with lymph node positivity ( p = 0. 052), poor prognosis ( p = 0. 014), and P - Akt expression in invasive ductal carcinoma.	FOXO3a,49,55,Gene_or_gene_product	Akt,77,80,Gene_or_gene_product	Akt,87,90,Gene_or_gene_product	breast cancer tissue,106,126,Cancer	nuclear,146,153,Cellular_component	FOXO3a,154,160,Gene_or_gene_product	lymph node,181,191,Multi	Akt,256,259,Gene_or_gene_product	invasive ductal carcinoma,274,299,Cancer	"[{""token"": ""FOXO3a"", ""start_span"": 49, ""end_span"": 55, ""type"": ""Gene_or_gene_product""}, {""token"": ""Akt"", ""start_span"": 77, ""end_span"": 80, ""type"": ""Gene_or_gene_product""}, {""token"": ""Akt"", ""start_span"": 87, ""end_span"": 90, ""type"": ""Gene_or_gene_product""}, {""token"": ""breast cancer tissue"", ""start_span"": 106, ""end_span"": 126, ""type"": ""Cancer""}, {""token"": ""nuclear"", ""start_span"": 146, ""end_span"": 153, ""type"": ""Cellular_component""}, {""token"": ""FOXO3a"", ""start_span"": 154, ""end_span"": 160, ""type"": ""Gene_or_gene_product""}, {""token"": ""lymph node"", ""start_span"": 181, ""end_span"": 191, ""type"": ""Multi""}, {""token"": ""Akt"", ""start_span"": 256, ""end_span"": 259, ""type"": ""Gene_or_gene_product""}, {""token"": ""invasive ductal carcinoma"", ""start_span"": 274, ""end_span"": 299, ""type"": ""Cancer""}]"	train
Using tamoxifen and doxorubicin - sensitive and - resistant breast cancer cell lines as models, we found that doxorubicin - but not tamoxifen - resistance is associated with nuclear accumulation of FOXO3a, consistent with the finding that sustained nuclear FOXO3a is associated with poor prognosis.	tamoxifen,6,15,Chemical	doxorubicin,20,31,Chemical	breast cancer cell lines,60,84,Cell	doxorubicin,110,121,Chemical	tamoxifen,132,141,Chemical	nuclear,174,181,Cellular_component	FOXO3a,198,204,Gene_or_gene_product	nuclear,249,256,Cellular_component	FOXO3a,257,263,Gene_or_gene_product	"[{""token"": ""tamoxifen"", ""start_span"": 6, ""end_span"": 15, ""type"": ""Chemical""}, {""token"": ""doxorubicin"", ""start_span"": 20, ""end_span"": 31, ""type"": ""Chemical""}, {""token"": ""breast cancer cell lines"", ""start_span"": 60, ""end_span"": 84, ""type"": ""Cell""}, {""token"": ""doxorubicin"", ""start_span"": 110, ""end_span"": 121, ""type"": ""Chemical""}, {""token"": ""tamoxifen"", ""start_span"": 132, ""end_span"": 141, ""type"": ""Chemical""}, {""token"": ""nuclear"", ""start_span"": 174, ""end_span"": 181, ""type"": ""Cellular_component""}, {""token"": ""FOXO3a"", ""start_span"": 198, ""end_span"": 204, ""type"": ""Gene_or_gene_product""}, {""token"": ""nuclear"", ""start_span"": 249, ""end_span"": 256, ""type"": ""Cellular_component""}, {""token"": ""FOXO3a"", ""start_span"": 257, ""end_span"": 263, ""type"": ""Gene_or_gene_product""}]"	train
Furthermore, the expression levels of NF - kappaB - regulated metastasis - related molecules, such as fibronectin, beta1 integrin, MMP - 1, - 2, - 9, and - 14, and VEGF - C, were upregulated in the highly metastatic cells.	NF - kappaB,38,49,Gene_or_gene_product	fibronectin,102,113,Gene_or_gene_product	beta1 integrin,115,129,Gene_or_gene_product	MMP - 1,131,138,Gene_or_gene_product	- 2,140,143,Gene_or_gene_product	- 9,145,148,Gene_or_gene_product	- 14,154,158,Gene_or_gene_product	VEGF - C,164,172,Gene_or_gene_product	cells,216,221,Cell	"[{""token"": ""NF - kappaB"", ""start_span"": 38, ""end_span"": 49, ""type"": ""Gene_or_gene_product""}, {""token"": ""fibronectin"", ""start_span"": 102, ""end_span"": 113, ""type"": ""Gene_or_gene_product""}, {""token"": ""beta1 integrin"", ""start_span"": 115, ""end_span"": 129, ""type"": ""Gene_or_gene_product""}, {""token"": ""MMP - 1"", ""start_span"": 131, ""end_span"": 138, ""type"": ""Gene_or_gene_product""}, {""token"": ""- 2"", ""start_span"": 140, ""end_span"": 143, ""type"": ""Gene_or_gene_product""}, {""token"": ""- 9"", ""start_span"": 145, ""end_span"": 148, ""type"": ""Gene_or_gene_product""}, {""token"": ""- 14"", ""start_span"": 154, ""end_span"": 158, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF - C"", ""start_span"": 164, ""end_span"": 172, ""type"": ""Gene_or_gene_product""}, {""token"": ""cells"", ""start_span"": 216, ""end_span"": 221, ""type"": ""Cell""}]"	train
Two approaches were used to measure protein kinase C: assay of intact cells for inhibition of epidermal growth factor ( EGF) binding in response to phorbol dibutyrate ( PDBu); and assay of detergent extracts for total calcium, phospholipid - dependent kinase activity.	protein kinase C,36,52,Gene_or_gene_product	cells,70,75,Cell	epidermal growth factor,94,117,Gene_or_gene_product	EGF,120,123,Gene_or_gene_product	phorbol dibutyrate,148,166,Chemical	PDBu,169,173,Chemical	extracts,199,207,Organism_substance	calcium,218,225,Chemical	phospholipid,227,239,Chemical	"[{""token"": ""protein kinase C"", ""start_span"": 36, ""end_span"": 52, ""type"": ""Gene_or_gene_product""}, {""token"": ""cells"", ""start_span"": 70, ""end_span"": 75, ""type"": ""Cell""}, {""token"": ""epidermal growth factor"", ""start_span"": 94, ""end_span"": 117, ""type"": ""Gene_or_gene_product""}, {""token"": ""EGF"", ""start_span"": 120, ""end_span"": 123, ""type"": ""Gene_or_gene_product""}, {""token"": ""phorbol dibutyrate"", ""start_span"": 148, ""end_span"": 166, ""type"": ""Chemical""}, {""token"": ""PDBu"", ""start_span"": 169, ""end_span"": 173, ""type"": ""Chemical""}, {""token"": ""extracts"", ""start_span"": 199, ""end_span"": 207, ""type"": ""Organism_substance""}, {""token"": ""calcium"", ""start_span"": 218, ""end_span"": 225, ""type"": ""Chemical""}, {""token"": ""phospholipid"", ""start_span"": 227, ""end_span"": 239, ""type"": ""Chemical""}]"	train
The human T - cell leukemia viruses HTLV - I and HTLV - II are unique among the transforming retroviruses of vertebrates in their ability to transform human T cells in vitro and in their close association with human malignancies ( T - cell lymphomas and leukemia).	human T - cell leukemia viruses HTLV - I,4,44,Organism	HTLV - II,49,58,Organism	retroviruses,93,105,Organism	human,151,156,Organism	T cells,157,164,Cell	human,210,215,Organism	malignancies,216,228,Cancer	T - cell lymphomas,231,249,Cancer	leukemia,254,262,Cancer	"[{""token"": ""human T - cell leukemia viruses HTLV - I"", ""start_span"": 4, ""end_span"": 44, ""type"": ""Organism""}, {""token"": ""HTLV - II"", ""start_span"": 49, ""end_span"": 58, ""type"": ""Organism""}, {""token"": ""retroviruses"", ""start_span"": 93, ""end_span"": 105, ""type"": ""Organism""}, {""token"": ""human"", ""start_span"": 151, ""end_span"": 156, ""type"": ""Organism""}, {""token"": ""T cells"", ""start_span"": 157, ""end_span"": 164, ""type"": ""Cell""}, {""token"": ""human"", ""start_span"": 210, ""end_span"": 215, ""type"": ""Organism""}, {""token"": ""malignancies"", ""start_span"": 216, ""end_span"": 228, ""type"": ""Cancer""}, {""token"": ""T - cell lymphomas"", ""start_span"": 231, ""end_span"": 249, ""type"": ""Cancer""}, {""token"": ""leukemia"", ""start_span"": 254, ""end_span"": 262, ""type"": ""Cancer""}]"	train
Although insulin sensitivity of skeletal muscle was also reduced in patients with lymphoma, the net insulin effect may counteract imbalance between glucose uptake of tumor and muscle, offering a potential means to circumvent at least some metabolic abnormalities found in cancer.	insulin,9,16,Gene_or_gene_product	skeletal muscle,32,47,Organ	patients,68,76,Organism	lymphoma,82,90,Cancer	insulin,100,107,Gene_or_gene_product	glucose,148,155,Chemical	tumor,166,171,Cancer	muscle,176,182,Organ	cancer,272,278,Cancer	"[{""token"": ""insulin"", ""start_span"": 9, ""end_span"": 16, ""type"": ""Gene_or_gene_product""}, {""token"": ""skeletal muscle"", ""start_span"": 32, ""end_span"": 47, ""type"": ""Organ""}, {""token"": ""patients"", ""start_span"": 68, ""end_span"": 76, ""type"": ""Organism""}, {""token"": ""lymphoma"", ""start_span"": 82, ""end_span"": 90, ""type"": ""Cancer""}, {""token"": ""insulin"", ""start_span"": 100, ""end_span"": 107, ""type"": ""Gene_or_gene_product""}, {""token"": ""glucose"", ""start_span"": 148, ""end_span"": 155, ""type"": ""Chemical""}, {""token"": ""tumor"", ""start_span"": 166, ""end_span"": 171, ""type"": ""Cancer""}, {""token"": ""muscle"", ""start_span"": 176, ""end_span"": 182, ""type"": ""Organ""}, {""token"": ""cancer"", ""start_span"": 272, ""end_span"": 278, ""type"": ""Cancer""}]"	train
Plasmid DNA encoding each of the three principal human VEGF isoforms ( phVEGF121, phVEGF165, or phVEGF189) was applied to the hydrogel polymer coating of an angioplasty balloon and delivered percutaneously to one iliac artery of rabbits with operatively induced hindlimb ischemia.	Plasmid DNA,0,11,Cellular_component	human,49,54,Organism	VEGF,55,59,Gene_or_gene_product	phVEGF121,71,80,Gene_or_gene_product	phVEGF165,82,91,Gene_or_gene_product	phVEGF189,96,105,Gene_or_gene_product	iliac artery,213,225,Multi	rabbits,229,236,Organism	hindlimb,262,270,Organism_subdivision	"[{""token"": ""Plasmid DNA"", ""start_span"": 0, ""end_span"": 11, ""type"": ""Cellular_component""}, {""token"": ""human"", ""start_span"": 49, ""end_span"": 54, ""type"": ""Organism""}, {""token"": ""VEGF"", ""start_span"": 55, ""end_span"": 59, ""type"": ""Gene_or_gene_product""}, {""token"": ""phVEGF121"", ""start_span"": 71, ""end_span"": 80, ""type"": ""Gene_or_gene_product""}, {""token"": ""phVEGF165"", ""start_span"": 82, ""end_span"": 91, ""type"": ""Gene_or_gene_product""}, {""token"": ""phVEGF189"", ""start_span"": 96, ""end_span"": 105, ""type"": ""Gene_or_gene_product""}, {""token"": ""iliac artery"", ""start_span"": 213, ""end_span"": 225, ""type"": ""Multi""}, {""token"": ""rabbits"", ""start_span"": 229, ""end_span"": 236, ""type"": ""Organism""}, {""token"": ""hindlimb"", ""start_span"": 262, ""end_span"": 270, ""type"": ""Organism_subdivision""}]"	train
Although extracellular signal - regulated protein kinase 1 / 2 ( ERK1 / 2), c - Jun N - terminal kinase 1 ( JNK1), and p38 were activated after denudation, the activation of ERK1 and p38 was more rapid and prominent.	extracellular signal - regulated protein kinase 1,9,58,Gene_or_gene_product	2,61,62,Gene_or_gene_product	ERK1,65,69,Gene_or_gene_product	2,72,73,Gene_or_gene_product	c - Jun N - terminal kinase 1,76,105,Gene_or_gene_product	JNK1,108,112,Gene_or_gene_product	p38,119,122,Gene_or_gene_product	ERK1,174,178,Gene_or_gene_product	p38,183,186,Gene_or_gene_product	"[{""token"": ""extracellular signal - regulated protein kinase 1"", ""start_span"": 9, ""end_span"": 58, ""type"": ""Gene_or_gene_product""}, {""token"": ""2"", ""start_span"": 61, ""end_span"": 62, ""type"": ""Gene_or_gene_product""}, {""token"": ""ERK1"", ""start_span"": 65, ""end_span"": 69, ""type"": ""Gene_or_gene_product""}, {""token"": ""2"", ""start_span"": 72, ""end_span"": 73, ""type"": ""Gene_or_gene_product""}, {""token"": ""c - Jun N - terminal kinase 1"", ""start_span"": 76, ""end_span"": 105, ""type"": ""Gene_or_gene_product""}, {""token"": ""JNK1"", ""start_span"": 108, ""end_span"": 112, ""type"": ""Gene_or_gene_product""}, {""token"": ""p38"", ""start_span"": 119, ""end_span"": 122, ""type"": ""Gene_or_gene_product""}, {""token"": ""ERK1"", ""start_span"": 174, ""end_span"": 178, ""type"": ""Gene_or_gene_product""}, {""token"": ""p38"", ""start_span"": 183, ""end_span"": 186, ""type"": ""Gene_or_gene_product""}]"	train
Recently VEGF - B and VEGF - C, two new VEGF family members, have been identified that bind to the tyrosine kinase receptors flt - 1 ( VEGFR1), KDR ( VEGFR2), and flt - 4 ( VEGFR3).	VEGF - B,9,17,Gene_or_gene_product	VEGF - C,22,30,Gene_or_gene_product	VEGF,40,44,Gene_or_gene_product	flt - 1,125,132,Gene_or_gene_product	VEGFR1,135,141,Gene_or_gene_product	KDR,144,147,Gene_or_gene_product	VEGFR2,150,156,Gene_or_gene_product	flt - 4,163,170,Gene_or_gene_product	VEGFR3,173,179,Gene_or_gene_product	"[{""token"": ""VEGF - B"", ""start_span"": 9, ""end_span"": 17, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF - C"", ""start_span"": 22, ""end_span"": 30, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 40, ""end_span"": 44, ""type"": ""Gene_or_gene_product""}, {""token"": ""flt - 1"", ""start_span"": 125, ""end_span"": 132, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGFR1"", ""start_span"": 135, ""end_span"": 141, ""type"": ""Gene_or_gene_product""}, {""token"": ""KDR"", ""start_span"": 144, ""end_span"": 147, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGFR2"", ""start_span"": 150, ""end_span"": 156, ""type"": ""Gene_or_gene_product""}, {""token"": ""flt - 4"", ""start_span"": 163, ""end_span"": 170, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGFR3"", ""start_span"": 173, ""end_span"": 179, ""type"": ""Gene_or_gene_product""}]"	valid
Hck - mediated cellular transformation of murine fibroblasts is reverted by ectopic expression of a membrane - anchored allele of Cbl as assessed by the cellular morphology, suppression of anchorage independent growth, and an overall reduction in the total tyrosine phosphorylation levels within the cells.	Hck,0,3,Gene_or_gene_product	cellular,15,23,Cell	murine,42,48,Organism	fibroblasts,49,60,Cell	membrane,100,108,Cellular_component	Cbl,130,133,Gene_or_gene_product	cellular,153,161,Cell	tyrosine,257,265,Amino_acid	cells,300,305,Cell	"[{""token"": ""Hck"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Gene_or_gene_product""}, {""token"": ""cellular"", ""start_span"": 15, ""end_span"": 23, ""type"": ""Cell""}, {""token"": ""murine"", ""start_span"": 42, ""end_span"": 48, ""type"": ""Organism""}, {""token"": ""fibroblasts"", ""start_span"": 49, ""end_span"": 60, ""type"": ""Cell""}, {""token"": ""membrane"", ""start_span"": 100, ""end_span"": 108, ""type"": ""Cellular_component""}, {""token"": ""Cbl"", ""start_span"": 130, ""end_span"": 133, ""type"": ""Gene_or_gene_product""}, {""token"": ""cellular"", ""start_span"": 153, ""end_span"": 161, ""type"": ""Cell""}, {""token"": ""tyrosine"", ""start_span"": 257, ""end_span"": 265, ""type"": ""Amino_acid""}, {""token"": ""cells"", ""start_span"": 300, ""end_span"": 305, ""type"": ""Cell""}]"	valid
By using immunohistochemistry, Western blot, and real - time PCR the expression patterns of TSP - 1, TSP - 2, CD36, CD47, MMP - 2, and MMP - 9 were investigated in normal rat prostate tissue and five malignant Dunning sublines tissue.	TSP - 1,92,99,Gene_or_gene_product	TSP - 2,101,108,Gene_or_gene_product	CD36,110,114,Gene_or_gene_product	CD47,116,120,Gene_or_gene_product	MMP - 2,122,129,Gene_or_gene_product	MMP - 9,135,142,Gene_or_gene_product	rat,171,174,Organism	prostate tissue,175,190,Tissue	malignant Dunning sublines tissue,200,233,Tissue	"[{""token"": ""TSP - 1"", ""start_span"": 92, ""end_span"": 99, ""type"": ""Gene_or_gene_product""}, {""token"": ""TSP - 2"", ""start_span"": 101, ""end_span"": 108, ""type"": ""Gene_or_gene_product""}, {""token"": ""CD36"", ""start_span"": 110, ""end_span"": 114, ""type"": ""Gene_or_gene_product""}, {""token"": ""CD47"", ""start_span"": 116, ""end_span"": 120, ""type"": ""Gene_or_gene_product""}, {""token"": ""MMP - 2"", ""start_span"": 122, ""end_span"": 129, ""type"": ""Gene_or_gene_product""}, {""token"": ""MMP - 9"", ""start_span"": 135, ""end_span"": 142, ""type"": ""Gene_or_gene_product""}, {""token"": ""rat"", ""start_span"": 171, ""end_span"": 174, ""type"": ""Organism""}, {""token"": ""prostate tissue"", ""start_span"": 175, ""end_span"": 190, ""type"": ""Tissue""}, {""token"": ""malignant Dunning sublines tissue"", ""start_span"": 200, ""end_span"": 233, ""type"": ""Tissue""}]"	valid
Additionally, knockdown of p600 reduced transformation of cells expressing both BPV - 1 E6 and E7, as well as E6 alone, suggesting that the ability of E7 to transformed cells is mediated, at least in part, through its ability to bind p600.	p600,27,31,Gene_or_gene_product	cells,58,63,Cell	BPV - 1,80,87,Organism	E6,88,90,Gene_or_gene_product	E7,95,97,Gene_or_gene_product	E6,110,112,Gene_or_gene_product	E7,151,153,Gene_or_gene_product	cells,169,174,Cell	p600,234,238,Gene_or_gene_product	"[{""token"": ""p600"", ""start_span"": 27, ""end_span"": 31, ""type"": ""Gene_or_gene_product""}, {""token"": ""cells"", ""start_span"": 58, ""end_span"": 63, ""type"": ""Cell""}, {""token"": ""BPV - 1"", ""start_span"": 80, ""end_span"": 87, ""type"": ""Organism""}, {""token"": ""E6"", ""start_span"": 88, ""end_span"": 90, ""type"": ""Gene_or_gene_product""}, {""token"": ""E7"", ""start_span"": 95, ""end_span"": 97, ""type"": ""Gene_or_gene_product""}, {""token"": ""E6"", ""start_span"": 110, ""end_span"": 112, ""type"": ""Gene_or_gene_product""}, {""token"": ""E7"", ""start_span"": 151, ""end_span"": 153, ""type"": ""Gene_or_gene_product""}, {""token"": ""cells"", ""start_span"": 169, ""end_span"": 174, ""type"": ""Cell""}, {""token"": ""p600"", ""start_span"": 234, ""end_span"": 238, ""type"": ""Gene_or_gene_product""}]"	valid
Brain pericytes in culture had higher levels of endosialin / TEM 1 than TEMs - 2, - 3, - 4, - 5, - 7, and - 8.	Brain pericytes,0,15,Cell	endosialin,48,58,Gene_or_gene_product	TEM 1,61,66,Gene_or_gene_product	TEMs - 2,72,80,Gene_or_gene_product	- 3,82,85,Gene_or_gene_product	- 4,87,90,Gene_or_gene_product	- 5,92,95,Gene_or_gene_product	- 7,97,100,Gene_or_gene_product	- 8,106,109,Gene_or_gene_product	"[{""token"": ""Brain pericytes"", ""start_span"": 0, ""end_span"": 15, ""type"": ""Cell""}, {""token"": ""endosialin"", ""start_span"": 48, ""end_span"": 58, ""type"": ""Gene_or_gene_product""}, {""token"": ""TEM 1"", ""start_span"": 61, ""end_span"": 66, ""type"": ""Gene_or_gene_product""}, {""token"": ""TEMs - 2"", ""start_span"": 72, ""end_span"": 80, ""type"": ""Gene_or_gene_product""}, {""token"": ""- 3"", ""start_span"": 82, ""end_span"": 85, ""type"": ""Gene_or_gene_product""}, {""token"": ""- 4"", ""start_span"": 87, ""end_span"": 90, ""type"": ""Gene_or_gene_product""}, {""token"": ""- 5"", ""start_span"": 92, ""end_span"": 95, ""type"": ""Gene_or_gene_product""}, {""token"": ""- 7"", ""start_span"": 97, ""end_span"": 100, ""type"": ""Gene_or_gene_product""}, {""token"": ""- 8"", ""start_span"": 106, ""end_span"": 109, ""type"": ""Gene_or_gene_product""}]"	valid
Here, in order to characterize the role of the promoter that drives DSCR - 1s expression in mediating inducible expression in vivo and to determine the functional relevance of DSCR - 1s in inflammation, we targeted a DNA construct containing 1. 7 kb of the human DSCR1s promoter coupled to the lacZ reporter to the hypoxanthine guanine phosphoribosyl transferase ( Hprt) locus of mice.	DSCR - 1s,68,77,Gene_or_gene_product	DSCR - 1s,176,185,Gene_or_gene_product	DNA,217,220,Cellular_component	human,257,262,Organism	DSCR1s,263,269,Gene_or_gene_product	lacZ,294,298,Gene_or_gene_product	hypoxanthine guanine phosphoribosyl transferase,315,362,Gene_or_gene_product	Hprt,365,369,Gene_or_gene_product	mice,380,384,Organism	"[{""token"": ""DSCR - 1s"", ""start_span"": 68, ""end_span"": 77, ""type"": ""Gene_or_gene_product""}, {""token"": ""DSCR - 1s"", ""start_span"": 176, ""end_span"": 185, ""type"": ""Gene_or_gene_product""}, {""token"": ""DNA"", ""start_span"": 217, ""end_span"": 220, ""type"": ""Cellular_component""}, {""token"": ""human"", ""start_span"": 257, ""end_span"": 262, ""type"": ""Organism""}, {""token"": ""DSCR1s"", ""start_span"": 263, ""end_span"": 269, ""type"": ""Gene_or_gene_product""}, {""token"": ""lacZ"", ""start_span"": 294, ""end_span"": 298, ""type"": ""Gene_or_gene_product""}, {""token"": ""hypoxanthine guanine phosphoribosyl transferase"", ""start_span"": 315, ""end_span"": 362, ""type"": ""Gene_or_gene_product""}, {""token"": ""Hprt"", ""start_span"": 365, ""end_span"": 369, ""type"": ""Gene_or_gene_product""}, {""token"": ""mice"", ""start_span"": 380, ""end_span"": 384, ""type"": ""Organism""}]"	valid
Ploidy analysis was carried out on 39 EOGCs and immunohistochemistry of CDC4 / FBXW7 and its substrates c - myc, c - jun, Notch and cyclin E was performed on 204 gastric carcinomas using tissue microarrays ( TMAs).	EOGCs,38,43,Cancer	CDC4,72,76,Gene_or_gene_product	FBXW7,79,84,Gene_or_gene_product	c - myc,104,111,Gene_or_gene_product	c - jun,113,120,Gene_or_gene_product	Notch,122,127,Gene_or_gene_product	cyclin E,132,140,Gene_or_gene_product	gastric carcinomas,162,180,Cancer	tissue,187,193,Tissue	"[{""token"": ""EOGCs"", ""start_span"": 38, ""end_span"": 43, ""type"": ""Cancer""}, {""token"": ""CDC4"", ""start_span"": 72, ""end_span"": 76, ""type"": ""Gene_or_gene_product""}, {""token"": ""FBXW7"", ""start_span"": 79, ""end_span"": 84, ""type"": ""Gene_or_gene_product""}, {""token"": ""c - myc"", ""start_span"": 104, ""end_span"": 111, ""type"": ""Gene_or_gene_product""}, {""token"": ""c - jun"", ""start_span"": 113, ""end_span"": 120, ""type"": ""Gene_or_gene_product""}, {""token"": ""Notch"", ""start_span"": 122, ""end_span"": 127, ""type"": ""Gene_or_gene_product""}, {""token"": ""cyclin E"", ""start_span"": 132, ""end_span"": 140, ""type"": ""Gene_or_gene_product""}, {""token"": ""gastric carcinomas"", ""start_span"": 162, ""end_span"": 180, ""type"": ""Cancer""}, {""token"": ""tissue"", ""start_span"": 187, ""end_span"": 193, ""type"": ""Tissue""}]"	valid
Several regulatory and signaling molecules governing angiogenesis are of interest, including growth factors ( eg, vascular endothelial growth factor, platelet - derived growth factor, fibroblast growth factor, and epidermal growth factor), receptor tyrosine kinases, and transcription factors such as hypoxia inducible factor, as well as molecules involved in mitogen - activated protein kinase ( MAPK) and phosphoinositide 3 - kinase ( PI3K) signaling.	vascular endothelial growth factor,114,148,Gene_or_gene_product	platelet - derived growth factor,150,182,Gene_or_gene_product	fibroblast growth factor,184,208,Gene_or_gene_product	epidermal growth factor,214,237,Gene_or_gene_product	hypoxia inducible factor,301,325,Gene_or_gene_product	mitogen - activated protein kinase,360,394,Gene_or_gene_product	MAPK,397,401,Gene_or_gene_product	phosphoinositide 3 - kinase,407,434,Gene_or_gene_product	PI3K,437,441,Gene_or_gene_product	"[{""token"": ""vascular endothelial growth factor"", ""start_span"": 114, ""end_span"": 148, ""type"": ""Gene_or_gene_product""}, {""token"": ""platelet - derived growth factor"", ""start_span"": 150, ""end_span"": 182, ""type"": ""Gene_or_gene_product""}, {""token"": ""fibroblast growth factor"", ""start_span"": 184, ""end_span"": 208, ""type"": ""Gene_or_gene_product""}, {""token"": ""epidermal growth factor"", ""start_span"": 214, ""end_span"": 237, ""type"": ""Gene_or_gene_product""}, {""token"": ""hypoxia inducible factor"", ""start_span"": 301, ""end_span"": 325, ""type"": ""Gene_or_gene_product""}, {""token"": ""mitogen - activated protein kinase"", ""start_span"": 360, ""end_span"": 394, ""type"": ""Gene_or_gene_product""}, {""token"": ""MAPK"", ""start_span"": 397, ""end_span"": 401, ""type"": ""Gene_or_gene_product""}, {""token"": ""phosphoinositide 3 - kinase"", ""start_span"": 407, ""end_span"": 434, ""type"": ""Gene_or_gene_product""}, {""token"": ""PI3K"", ""start_span"": 437, ""end_span"": 441, ""type"": ""Gene_or_gene_product""}]"	valid
Multiple proteins involved in metastasis and the cytoskeletal reorganization signal pathway, including Ras, Cdc42, Rac1, RhoA, RhoB, PI3K and p38MAPK, were also inhibited by GA.	cytoskeletal,49,61,Cellular_component	Ras,103,106,Gene_or_gene_product	Cdc42,108,113,Gene_or_gene_product	Rac1,115,119,Gene_or_gene_product	RhoA,121,125,Gene_or_gene_product	RhoB,127,131,Gene_or_gene_product	PI3K,133,137,Gene_or_gene_product	p38MAPK,142,149,Gene_or_gene_product	GA,174,176,Chemical	"[{""token"": ""cytoskeletal"", ""start_span"": 49, ""end_span"": 61, ""type"": ""Cellular_component""}, {""token"": ""Ras"", ""start_span"": 103, ""end_span"": 106, ""type"": ""Gene_or_gene_product""}, {""token"": ""Cdc42"", ""start_span"": 108, ""end_span"": 113, ""type"": ""Gene_or_gene_product""}, {""token"": ""Rac1"", ""start_span"": 115, ""end_span"": 119, ""type"": ""Gene_or_gene_product""}, {""token"": ""RhoA"", ""start_span"": 121, ""end_span"": 125, ""type"": ""Gene_or_gene_product""}, {""token"": ""RhoB"", ""start_span"": 127, ""end_span"": 131, ""type"": ""Gene_or_gene_product""}, {""token"": ""PI3K"", ""start_span"": 133, ""end_span"": 137, ""type"": ""Gene_or_gene_product""}, {""token"": ""p38MAPK"", ""start_span"": 142, ""end_span"": 149, ""type"": ""Gene_or_gene_product""}, {""token"": ""GA"", ""start_span"": 174, ""end_span"": 176, ""type"": ""Chemical""}]"	valid
The activated PI3K ( phosphoinositide 3 - kinase) / Akt signalling pathway in LNCaP cells contributes to the phosphorylation of PFKFB2 at Ser466 and Ser483, resulting in the constitutive activation of PFK - 2 ( 6 - phosphofructo - 2 - kinase) activity.	PI3K,14,18,Gene_or_gene_product	phosphoinositide 3 - kinase,21,48,Gene_or_gene_product	Akt,52,55,Gene_or_gene_product	LNCaP cells,78,89,Cell	PFKFB2,128,134,Gene_or_gene_product	Ser466,138,144,Amino_acid	Ser483,149,155,Amino_acid	PFK - 2,201,208,Gene_or_gene_product	6 - phosphofructo - 2 - kinase,211,241,Gene_or_gene_product	"[{""token"": ""PI3K"", ""start_span"": 14, ""end_span"": 18, ""type"": ""Gene_or_gene_product""}, {""token"": ""phosphoinositide 3 - kinase"", ""start_span"": 21, ""end_span"": 48, ""type"": ""Gene_or_gene_product""}, {""token"": ""Akt"", ""start_span"": 52, ""end_span"": 55, ""type"": ""Gene_or_gene_product""}, {""token"": ""LNCaP cells"", ""start_span"": 78, ""end_span"": 89, ""type"": ""Cell""}, {""token"": ""PFKFB2"", ""start_span"": 128, ""end_span"": 134, ""type"": ""Gene_or_gene_product""}, {""token"": ""Ser466"", ""start_span"": 138, ""end_span"": 144, ""type"": ""Amino_acid""}, {""token"": ""Ser483"", ""start_span"": 149, ""end_span"": 155, ""type"": ""Amino_acid""}, {""token"": ""PFK - 2"", ""start_span"": 201, ""end_span"": 208, ""type"": ""Gene_or_gene_product""}, {""token"": ""6 - phosphofructo - 2 - kinase"", ""start_span"": 211, ""end_span"": 241, ""type"": ""Gene_or_gene_product""}]"	valid
Taken together, our results suggest that the induction of de novo lipid synthesis by androgen requires the transcriptional up - regulation of HK2 and PFKFB2, and phosphorylation of PFKFB2 generated by the PI3K / Akt signalling pathway to supply the source for lipogenesis from glucose in prostate cancer cells.	lipid,66,71,Chemical	androgen,85,93,Chemical	HK2,142,145,Gene_or_gene_product	PFKFB2,150,156,Gene_or_gene_product	PFKFB2,181,187,Gene_or_gene_product	PI3K,205,209,Gene_or_gene_product	Akt,212,215,Gene_or_gene_product	glucose,277,284,Chemical	prostate cancer cells,288,309,Cell	"[{""token"": ""lipid"", ""start_span"": 66, ""end_span"": 71, ""type"": ""Chemical""}, {""token"": ""androgen"", ""start_span"": 85, ""end_span"": 93, ""type"": ""Chemical""}, {""token"": ""HK2"", ""start_span"": 142, ""end_span"": 145, ""type"": ""Gene_or_gene_product""}, {""token"": ""PFKFB2"", ""start_span"": 150, ""end_span"": 156, ""type"": ""Gene_or_gene_product""}, {""token"": ""PFKFB2"", ""start_span"": 181, ""end_span"": 187, ""type"": ""Gene_or_gene_product""}, {""token"": ""PI3K"", ""start_span"": 205, ""end_span"": 209, ""type"": ""Gene_or_gene_product""}, {""token"": ""Akt"", ""start_span"": 212, ""end_span"": 215, ""type"": ""Gene_or_gene_product""}, {""token"": ""glucose"", ""start_span"": 277, ""end_span"": 284, ""type"": ""Chemical""}, {""token"": ""prostate cancer cells"", ""start_span"": 288, ""end_span"": 309, ""type"": ""Cell""}]"	valid
Thymidylate synthase ( TS) and dihydropyrimidine dehydrogenase ( DPD) are 5 - fluorouracil ( 5 - FU) metabolizing enzymes and are involved in the sensitivity of carcinoma patients to 5 - FU.	Thymidylate synthase,0,20,Gene_or_gene_product	TS,23,25,Gene_or_gene_product	dihydropyrimidine dehydrogenase,31,62,Gene_or_gene_product	DPD,65,68,Gene_or_gene_product	5 - fluorouracil,74,90,Chemical	5 - FU,93,99,Chemical	carcinoma,161,170,Cancer	patients,171,179,Organism	5 - FU,183,189,Chemical	"[{""token"": ""Thymidylate synthase"", ""start_span"": 0, ""end_span"": 20, ""type"": ""Gene_or_gene_product""}, {""token"": ""TS"", ""start_span"": 23, ""end_span"": 25, ""type"": ""Gene_or_gene_product""}, {""token"": ""dihydropyrimidine dehydrogenase"", ""start_span"": 31, ""end_span"": 62, ""type"": ""Gene_or_gene_product""}, {""token"": ""DPD"", ""start_span"": 65, ""end_span"": 68, ""type"": ""Gene_or_gene_product""}, {""token"": ""5 - fluorouracil"", ""start_span"": 74, ""end_span"": 90, ""type"": ""Chemical""}, {""token"": ""5 - FU"", ""start_span"": 93, ""end_span"": 99, ""type"": ""Chemical""}, {""token"": ""carcinoma"", ""start_span"": 161, ""end_span"": 170, ""type"": ""Cancer""}, {""token"": ""patients"", ""start_span"": 171, ""end_span"": 179, ""type"": ""Organism""}, {""token"": ""5 - FU"", ""start_span"": 183, ""end_span"": 189, ""type"": ""Chemical""}]"	valid
The different tumorigenic potential of SV40 in WAP - T and WAP - mutCK1delta / WAP - T tumors was also reflected by a significantly different expression of various genes known to be involved in tumor progression, specifically of those involved in wnt - signaling and DNA repair.	SV40,39,43,Organism	WAP - T,47,54,Gene_or_gene_product	WAP,59,62,Gene_or_gene_product	mutCK1delta,65,76,Gene_or_gene_product	WAP - T,79,86,Gene_or_gene_product	tumors,87,93,Cancer	tumor,194,199,Cancer	wnt,247,250,Gene_or_gene_product	DNA,267,270,Cellular_component	"[{""token"": ""SV40"", ""start_span"": 39, ""end_span"": 43, ""type"": ""Organism""}, {""token"": ""WAP - T"", ""start_span"": 47, ""end_span"": 54, ""type"": ""Gene_or_gene_product""}, {""token"": ""WAP"", ""start_span"": 59, ""end_span"": 62, ""type"": ""Gene_or_gene_product""}, {""token"": ""mutCK1delta"", ""start_span"": 65, ""end_span"": 76, ""type"": ""Gene_or_gene_product""}, {""token"": ""WAP - T"", ""start_span"": 79, ""end_span"": 86, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumors"", ""start_span"": 87, ""end_span"": 93, ""type"": ""Cancer""}, {""token"": ""tumor"", ""start_span"": 194, ""end_span"": 199, ""type"": ""Cancer""}, {""token"": ""wnt"", ""start_span"": 247, ""end_span"": 250, ""type"": ""Gene_or_gene_product""}, {""token"": ""DNA"", ""start_span"": 267, ""end_span"": 270, ""type"": ""Cellular_component""}]"	valid
From in vivo experiments using new methods such as the rabbit cornea, it is now becoming clear that the growth of a capillary involves an ordered sequence of events that includes lysis of the basement membrane of a parent venule, directional migration of capillary endothelial cells toward the angiogenic stimulus, lumen formation, development of branches, and anastomosis of the tip of one tube with another to form a loop.	rabbit,55,61,Organism	cornea,62,68,Multi	capillary,116,125,Tissue	basement membrane,192,209,Cellular_component	venule,222,228,Multi	capillary endothelial cells,255,282,Cell	lumen,315,320,Immaterial_anatomical_entity	branches,347,355,Tissue	tube,391,395,Tissue	"[{""token"": ""rabbit"", ""start_span"": 55, ""end_span"": 61, ""type"": ""Organism""}, {""token"": ""cornea"", ""start_span"": 62, ""end_span"": 68, ""type"": ""Multi""}, {""token"": ""capillary"", ""start_span"": 116, ""end_span"": 125, ""type"": ""Tissue""}, {""token"": ""basement membrane"", ""start_span"": 192, ""end_span"": 209, ""type"": ""Cellular_component""}, {""token"": ""venule"", ""start_span"": 222, ""end_span"": 228, ""type"": ""Multi""}, {""token"": ""capillary endothelial cells"", ""start_span"": 255, ""end_span"": 282, ""type"": ""Cell""}, {""token"": ""lumen"", ""start_span"": 315, ""end_span"": 320, ""type"": ""Immaterial_anatomical_entity""}, {""token"": ""branches"", ""start_span"": 347, ""end_span"": 355, ""type"": ""Tissue""}, {""token"": ""tube"", ""start_span"": 391, ""end_span"": 395, ""type"": ""Tissue""}]"	valid
H4IIEC3 ( H4), a differentiated rat hepatoma line and H5, its dedifferentiated subclone, were investigated as proliferating spheroids and as implanted subcutaneous tumors in juvenile rats.	H4IIEC3,0,7,Cell	H4,10,12,Cell	rat,32,35,Organism	hepatoma line,36,49,Cell	H5,54,56,Cell	subclone,79,87,Cell	spheroids,124,133,Cell	subcutaneous tumors,151,170,Cancer	juvenile rats,174,187,Organism	"[{""token"": ""H4IIEC3"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Cell""}, {""token"": ""H4"", ""start_span"": 10, ""end_span"": 12, ""type"": ""Cell""}, {""token"": ""rat"", ""start_span"": 32, ""end_span"": 35, ""type"": ""Organism""}, {""token"": ""hepatoma line"", ""start_span"": 36, ""end_span"": 49, ""type"": ""Cell""}, {""token"": ""H5"", ""start_span"": 54, ""end_span"": 56, ""type"": ""Cell""}, {""token"": ""subclone"", ""start_span"": 79, ""end_span"": 87, ""type"": ""Cell""}, {""token"": ""spheroids"", ""start_span"": 124, ""end_span"": 133, ""type"": ""Cell""}, {""token"": ""subcutaneous tumors"", ""start_span"": 151, ""end_span"": 170, ""type"": ""Cancer""}, {""token"": ""juvenile rats"", ""start_span"": 174, ""end_span"": 187, ""type"": ""Organism""}]"	valid
Two of the mutations included a G to C substitution at codon 12, and a G to A substitution at codon 18, resulting in a glycine to arginine, and an alanine to threonine change at these amino acids, respectively.	G,32,33,Chemical	C,37,38,Chemical	G,71,72,Chemical	A,76,77,Chemical	glycine,119,126,Amino_acid	arginine,130,138,Amino_acid	alanine,147,154,Amino_acid	threonine,158,167,Amino_acid	amino acids,184,195,Amino_acid	"[{""token"": ""G"", ""start_span"": 32, ""end_span"": 33, ""type"": ""Chemical""}, {""token"": ""C"", ""start_span"": 37, ""end_span"": 38, ""type"": ""Chemical""}, {""token"": ""G"", ""start_span"": 71, ""end_span"": 72, ""type"": ""Chemical""}, {""token"": ""A"", ""start_span"": 76, ""end_span"": 77, ""type"": ""Chemical""}, {""token"": ""glycine"", ""start_span"": 119, ""end_span"": 126, ""type"": ""Amino_acid""}, {""token"": ""arginine"", ""start_span"": 130, ""end_span"": 138, ""type"": ""Amino_acid""}, {""token"": ""alanine"", ""start_span"": 147, ""end_span"": 154, ""type"": ""Amino_acid""}, {""token"": ""threonine"", ""start_span"": 158, ""end_span"": 167, ""type"": ""Amino_acid""}, {""token"": ""amino acids"", ""start_span"": 184, ""end_span"": 195, ""type"": ""Amino_acid""}]"	valid
Levels of uPA, urokinase - plasminogen activator receptor ( uPAR) and plasminogen activator inhibitor - 1 ( PAI - 1) were measured semiquantitatively in paraffin sections of tumours from 147 patients with NSCLC.	uPA,10,13,Gene_or_gene_product	urokinase - plasminogen activator receptor,15,57,Gene_or_gene_product	uPAR,60,64,Gene_or_gene_product	plasminogen activator inhibitor - 1,70,105,Gene_or_gene_product	PAI - 1,108,115,Gene_or_gene_product	sections,162,170,Cancer	tumours,174,181,Cancer	patients,191,199,Organism	NSCLC,205,210,Cancer	"[{""token"": ""uPA"", ""start_span"": 10, ""end_span"": 13, ""type"": ""Gene_or_gene_product""}, {""token"": ""urokinase - plasminogen activator receptor"", ""start_span"": 15, ""end_span"": 57, ""type"": ""Gene_or_gene_product""}, {""token"": ""uPAR"", ""start_span"": 60, ""end_span"": 64, ""type"": ""Gene_or_gene_product""}, {""token"": ""plasminogen activator inhibitor - 1"", ""start_span"": 70, ""end_span"": 105, ""type"": ""Gene_or_gene_product""}, {""token"": ""PAI - 1"", ""start_span"": 108, ""end_span"": 115, ""type"": ""Gene_or_gene_product""}, {""token"": ""sections"", ""start_span"": 162, ""end_span"": 170, ""type"": ""Cancer""}, {""token"": ""tumours"", ""start_span"": 174, ""end_span"": 181, ""type"": ""Cancer""}, {""token"": ""patients"", ""start_span"": 191, ""end_span"": 199, ""type"": ""Organism""}, {""token"": ""NSCLC"", ""start_span"": 205, ""end_span"": 210, ""type"": ""Cancer""}]"	valid
Highly specialized cells, the thyrocytes, express a thyroid - specific set of genes for thyroglobulin ( Tg), thyroperoxidase, and the transcription factors TTF - 1, TTF - 2, and Pax - 8.	cells,19,24,Cell	thyrocytes,30,40,Cell	thyroid,52,59,Organ	thyroglobulin,88,101,Gene_or_gene_product	Tg,104,106,Gene_or_gene_product	thyroperoxidase,109,124,Gene_or_gene_product	TTF - 1,156,163,Gene_or_gene_product	TTF - 2,165,172,Gene_or_gene_product	Pax - 8,178,185,Gene_or_gene_product	"[{""token"": ""cells"", ""start_span"": 19, ""end_span"": 24, ""type"": ""Cell""}, {""token"": ""thyrocytes"", ""start_span"": 30, ""end_span"": 40, ""type"": ""Cell""}, {""token"": ""thyroid"", ""start_span"": 52, ""end_span"": 59, ""type"": ""Organ""}, {""token"": ""thyroglobulin"", ""start_span"": 88, ""end_span"": 101, ""type"": ""Gene_or_gene_product""}, {""token"": ""Tg"", ""start_span"": 104, ""end_span"": 106, ""type"": ""Gene_or_gene_product""}, {""token"": ""thyroperoxidase"", ""start_span"": 109, ""end_span"": 124, ""type"": ""Gene_or_gene_product""}, {""token"": ""TTF - 1"", ""start_span"": 156, ""end_span"": 163, ""type"": ""Gene_or_gene_product""}, {""token"": ""TTF - 2"", ""start_span"": 165, ""end_span"": 172, ""type"": ""Gene_or_gene_product""}, {""token"": ""Pax - 8"", ""start_span"": 178, ""end_span"": 185, ""type"": ""Gene_or_gene_product""}]"	test
Constitutively active RhoA ( FRTL - 5 - RhoA QL cells) exhibited a fibroblast - like phenotype with organized actin fibers, whereas cells expressing the RhoA negative dominant phenotype ( FRTL - 5 - RhoA N19 cells) present a rounded morphology and lose normal cytoskeletal architecture.	RhoA,22,26,Gene_or_gene_product	RhoA,40,44,Gene_or_gene_product	fibroblast,67,77,Cell	actin,110,115,Gene_or_gene_product	fibers,116,122,Cellular_component	cells,132,137,Cell	RhoA,153,157,Gene_or_gene_product	FRTL - 5 - RhoA N19 cells,188,213,Cell	cytoskeletal,260,272,Cellular_component	"[{""token"": ""RhoA"", ""start_span"": 22, ""end_span"": 26, ""type"": ""Gene_or_gene_product""}, {""token"": ""RhoA"", ""start_span"": 40, ""end_span"": 44, ""type"": ""Gene_or_gene_product""}, {""token"": ""fibroblast"", ""start_span"": 67, ""end_span"": 77, ""type"": ""Cell""}, {""token"": ""actin"", ""start_span"": 110, ""end_span"": 115, ""type"": ""Gene_or_gene_product""}, {""token"": ""fibers"", ""start_span"": 116, ""end_span"": 122, ""type"": ""Cellular_component""}, {""token"": ""cells"", ""start_span"": 132, ""end_span"": 137, ""type"": ""Cell""}, {""token"": ""RhoA"", ""start_span"": 153, ""end_span"": 157, ""type"": ""Gene_or_gene_product""}, {""token"": ""FRTL - 5 - RhoA N19 cells"", ""start_span"": 188, ""end_span"": 213, ""type"": ""Cell""}, {""token"": ""cytoskeletal"", ""start_span"": 260, ""end_span"": 272, ""type"": ""Cellular_component""}]"	test
Complexes containing VEGF165, NRP1, and KDR were also formed in an intercellular fashion by co - culture of EC expressing KDR only, with cells expressing NRP1 only, for example, breast carcinoma cells.	VEGF165,21,28,Gene_or_gene_product	NRP1,30,34,Gene_or_gene_product	KDR,40,43,Gene_or_gene_product	intercellular,67,80,Immaterial_anatomical_entity	EC,108,110,Cell	KDR,122,125,Gene_or_gene_product	cells,137,142,Cell	NRP1,154,158,Gene_or_gene_product	breast carcinoma cells,178,200,Cell	"[{""token"": ""VEGF165"", ""start_span"": 21, ""end_span"": 28, ""type"": ""Gene_or_gene_product""}, {""token"": ""NRP1"", ""start_span"": 30, ""end_span"": 34, ""type"": ""Gene_or_gene_product""}, {""token"": ""KDR"", ""start_span"": 40, ""end_span"": 43, ""type"": ""Gene_or_gene_product""}, {""token"": ""intercellular"", ""start_span"": 67, ""end_span"": 80, ""type"": ""Immaterial_anatomical_entity""}, {""token"": ""EC"", ""start_span"": 108, ""end_span"": 110, ""type"": ""Cell""}, {""token"": ""KDR"", ""start_span"": 122, ""end_span"": 125, ""type"": ""Gene_or_gene_product""}, {""token"": ""cells"", ""start_span"": 137, ""end_span"": 142, ""type"": ""Cell""}, {""token"": ""NRP1"", ""start_span"": 154, ""end_span"": 158, ""type"": ""Gene_or_gene_product""}, {""token"": ""breast carcinoma cells"", ""start_span"": 178, ""end_span"": 200, ""type"": ""Cell""}]"	test
The expression of JUN, ERBB2, MYC, cyclin D, PCNA, bFGF, VEGF and Hsp70 proteins revealed a positive correlation to lymph node involvement.	JUN,18,21,Gene_or_gene_product	ERBB2,23,28,Gene_or_gene_product	MYC,30,33,Gene_or_gene_product	cyclin D,35,43,Gene_or_gene_product	PCNA,45,49,Gene_or_gene_product	bFGF,51,55,Gene_or_gene_product	VEGF,57,61,Gene_or_gene_product	Hsp70,66,71,Gene_or_gene_product	lymph node,116,126,Multi	"[{""token"": ""JUN"", ""start_span"": 18, ""end_span"": 21, ""type"": ""Gene_or_gene_product""}, {""token"": ""ERBB2"", ""start_span"": 23, ""end_span"": 28, ""type"": ""Gene_or_gene_product""}, {""token"": ""MYC"", ""start_span"": 30, ""end_span"": 33, ""type"": ""Gene_or_gene_product""}, {""token"": ""cyclin D"", ""start_span"": 35, ""end_span"": 43, ""type"": ""Gene_or_gene_product""}, {""token"": ""PCNA"", ""start_span"": 45, ""end_span"": 49, ""type"": ""Gene_or_gene_product""}, {""token"": ""bFGF"", ""start_span"": 51, ""end_span"": 55, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 57, ""end_span"": 61, ""type"": ""Gene_or_gene_product""}, {""token"": ""Hsp70"", ""start_span"": 66, ""end_span"": 71, ""type"": ""Gene_or_gene_product""}, {""token"": ""lymph node"", ""start_span"": 116, ""end_span"": 126, ""type"": ""Multi""}]"	test
Administration of 317615 x 2HCI orally twice daily to nude mice bearing subcutaneous MX - 1 tumors or SKOV - 3 tumors resulted in a decreased number of intratumoral vessels as determined by CD31 and CD105 staining with decreases of 35% and 43% in MX - 1 tumors and 60% and 75% in SKOV - 3 tumors, respectively.	317615 x 2HCI,18,31,Chemical	nude mice,54,63,Organism	MX - 1 tumors,85,98,Cancer	SKOV - 3 tumors,102,117,Cancer	intratumoral vessels,152,172,Multi	CD31,190,194,Gene_or_gene_product	CD105,199,204,Gene_or_gene_product	MX - 1 tumors,247,260,Cancer	SKOV - 3 tumors,280,295,Cancer	"[{""token"": ""317615 x 2HCI"", ""start_span"": 18, ""end_span"": 31, ""type"": ""Chemical""}, {""token"": ""nude mice"", ""start_span"": 54, ""end_span"": 63, ""type"": ""Organism""}, {""token"": ""MX - 1 tumors"", ""start_span"": 85, ""end_span"": 98, ""type"": ""Cancer""}, {""token"": ""SKOV - 3 tumors"", ""start_span"": 102, ""end_span"": 117, ""type"": ""Cancer""}, {""token"": ""intratumoral vessels"", ""start_span"": 152, ""end_span"": 172, ""type"": ""Multi""}, {""token"": ""CD31"", ""start_span"": 190, ""end_span"": 194, ""type"": ""Gene_or_gene_product""}, {""token"": ""CD105"", ""start_span"": 199, ""end_span"": 204, ""type"": ""Gene_or_gene_product""}, {""token"": ""MX - 1 tumors"", ""start_span"": 247, ""end_span"": 260, ""type"": ""Cancer""}, {""token"": ""SKOV - 3 tumors"", ""start_span"": 280, ""end_span"": 295, ""type"": ""Cancer""}]"	test
HGF were stimulated with lipopolysaccharide ( LPS), vesicle ( Ve) and outer membrane protein ( OMP) from Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis.	HGF,0,3,Cell	lipopolysaccharide,25,43,Chemical	LPS,46,49,Chemical	vesicle,52,59,Gene_or_gene_product	Ve,62,64,Gene_or_gene_product	outer membrane protein,70,92,Gene_or_gene_product	OMP,95,98,Gene_or_gene_product	Actinobacillus actinomycetemcomitans,105,141,Organism	Porphyromonas gingivalis,146,170,Organism	"[{""token"": ""HGF"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Cell""}, {""token"": ""lipopolysaccharide"", ""start_span"": 25, ""end_span"": 43, ""type"": ""Chemical""}, {""token"": ""LPS"", ""start_span"": 46, ""end_span"": 49, ""type"": ""Chemical""}, {""token"": ""vesicle"", ""start_span"": 52, ""end_span"": 59, ""type"": ""Gene_or_gene_product""}, {""token"": ""Ve"", ""start_span"": 62, ""end_span"": 64, ""type"": ""Gene_or_gene_product""}, {""token"": ""outer membrane protein"", ""start_span"": 70, ""end_span"": 92, ""type"": ""Gene_or_gene_product""}, {""token"": ""OMP"", ""start_span"": 95, ""end_span"": 98, ""type"": ""Gene_or_gene_product""}, {""token"": ""Actinobacillus actinomycetemcomitans"", ""start_span"": 105, ""end_span"": 141, ""type"": ""Organism""}, {""token"": ""Porphyromonas gingivalis"", ""start_span"": 146, ""end_span"": 170, ""type"": ""Organism""}]"	test
Inhibition of the endothelial cell autocrine angiotensin system, with either the angiotensin - converting enzyme inhibitor lisinopril or the angiotensin II receptor antagonist sar1, ile8 - angiotensin II, leads to increased endothelial cell migration and urokinase - like plasminogen activator ( u - PA) activity ( Bell, L., and J. A. Madri. 1990. Am. J. Pathol. 137: 7 - 12).	endothelial cell,18,34,Cell	angiotensin,45,56,Gene_or_gene_product	angiotensin - converting enzyme,81,112,Gene_or_gene_product	lisinopril,123,133,Chemical	angiotensin II receptor,141,164,Gene_or_gene_product	sar1,176,180,Gene_or_gene_product	endothelial cell,224,240,Cell	urokinase - like plasminogen activator,255,293,Gene_or_gene_product	u - PA,296,302,Gene_or_gene_product	"[{""token"": ""endothelial cell"", ""start_span"": 18, ""end_span"": 34, ""type"": ""Cell""}, {""token"": ""angiotensin"", ""start_span"": 45, ""end_span"": 56, ""type"": ""Gene_or_gene_product""}, {""token"": ""angiotensin - converting enzyme"", ""start_span"": 81, ""end_span"": 112, ""type"": ""Gene_or_gene_product""}, {""token"": ""lisinopril"", ""start_span"": 123, ""end_span"": 133, ""type"": ""Chemical""}, {""token"": ""angiotensin II receptor"", ""start_span"": 141, ""end_span"": 164, ""type"": ""Gene_or_gene_product""}, {""token"": ""sar1"", ""start_span"": 176, ""end_span"": 180, ""type"": ""Gene_or_gene_product""}, {""token"": ""endothelial cell"", ""start_span"": 224, ""end_span"": 240, ""type"": ""Cell""}, {""token"": ""urokinase - like plasminogen activator"", ""start_span"": 255, ""end_span"": 293, ""type"": ""Gene_or_gene_product""}, {""token"": ""u - PA"", ""start_span"": 296, ""end_span"": 302, ""type"": ""Gene_or_gene_product""}]"	test
In this study we demonstrate that exposure of primary cultures of cardiac and vascular cells to hypoxia or AdCA5, an adenovirus encoding a constitutively active form of HIF - 1alpha, modulates the expression of genes encoding the angiogenic factors angiopoietin - 1 ( ANGPT1), ANGPT2, placental growth factor, and platelet - derived growth factor - B.	cardiac,66,73,Cell	vascular cells,78,92,Cell	AdCA5,107,112,Organism	HIF - 1alpha,169,181,Gene_or_gene_product	angiopoietin - 1,249,265,Gene_or_gene_product	ANGPT1,268,274,Gene_or_gene_product	ANGPT2,277,283,Gene_or_gene_product	placental growth factor,285,308,Gene_or_gene_product	platelet - derived growth factor - B,314,350,Gene_or_gene_product	"[{""token"": ""cardiac"", ""start_span"": 66, ""end_span"": 73, ""type"": ""Cell""}, {""token"": ""vascular cells"", ""start_span"": 78, ""end_span"": 92, ""type"": ""Cell""}, {""token"": ""AdCA5"", ""start_span"": 107, ""end_span"": 112, ""type"": ""Organism""}, {""token"": ""HIF - 1alpha"", ""start_span"": 169, ""end_span"": 181, ""type"": ""Gene_or_gene_product""}, {""token"": ""angiopoietin - 1"", ""start_span"": 249, ""end_span"": 265, ""type"": ""Gene_or_gene_product""}, {""token"": ""ANGPT1"", ""start_span"": 268, ""end_span"": 274, ""type"": ""Gene_or_gene_product""}, {""token"": ""ANGPT2"", ""start_span"": 277, ""end_span"": 283, ""type"": ""Gene_or_gene_product""}, {""token"": ""placental growth factor"", ""start_span"": 285, ""end_span"": 308, ""type"": ""Gene_or_gene_product""}, {""token"": ""platelet - derived growth factor - B"", ""start_span"": 314, ""end_span"": 350, ""type"": ""Gene_or_gene_product""}]"	test
Colon cancer overexpresses insulin - like growth factor 1 ( IGF1) and insulin - like growth factor 1 receptor ( IGF1 - R), as compared with normal or adenomatous mucosa, and it has been postulated that colorectal cancer cells depend on the IGF1 / IGF1 - R pathway for their growth and progression.	Colon cancer,0,12,Cancer	insulin - like growth factor 1,27,57,Gene_or_gene_product	IGF1,60,64,Gene_or_gene_product	insulin - like growth factor 1 receptor,70,109,Gene_or_gene_product	IGF1 - R,112,120,Gene_or_gene_product	adenomatous mucosa,150,168,Multi	colorectal cancer cells,202,225,Cell	IGF1,240,244,Gene_or_gene_product	IGF1 - R,247,255,Gene_or_gene_product	"[{""token"": ""Colon cancer"", ""start_span"": 0, ""end_span"": 12, ""type"": ""Cancer""}, {""token"": ""insulin - like growth factor 1"", ""start_span"": 27, ""end_span"": 57, ""type"": ""Gene_or_gene_product""}, {""token"": ""IGF1"", ""start_span"": 60, ""end_span"": 64, ""type"": ""Gene_or_gene_product""}, {""token"": ""insulin - like growth factor 1 receptor"", ""start_span"": 70, ""end_span"": 109, ""type"": ""Gene_or_gene_product""}, {""token"": ""IGF1 - R"", ""start_span"": 112, ""end_span"": 120, ""type"": ""Gene_or_gene_product""}, {""token"": ""adenomatous mucosa"", ""start_span"": 150, ""end_span"": 168, ""type"": ""Multi""}, {""token"": ""colorectal cancer cells"", ""start_span"": 202, ""end_span"": 225, ""type"": ""Cell""}, {""token"": ""IGF1"", ""start_span"": 240, ""end_span"": 244, ""type"": ""Gene_or_gene_product""}, {""token"": ""IGF1 - R"", ""start_span"": 247, ""end_span"": 255, ""type"": ""Gene_or_gene_product""}]"	test
Topotecan - and gimatecan induced moderate up - regulation of TRAIL - R1 and - R2 which resulted in a different cell response to the combination in androgen - independent cells ( DU - 145 and PC - 3).	Topotecan,0,9,Chemical	gimatecan,16,25,Chemical	TRAIL - R1,62,72,Gene_or_gene_product	- R2,77,81,Gene_or_gene_product	cell,112,116,Cell	androgen,148,156,Chemical	cells,171,176,Cell	DU - 145,179,187,Cell	PC - 3,192,198,Cell	"[{""token"": ""Topotecan"", ""start_span"": 0, ""end_span"": 9, ""type"": ""Chemical""}, {""token"": ""gimatecan"", ""start_span"": 16, ""end_span"": 25, ""type"": ""Chemical""}, {""token"": ""TRAIL - R1"", ""start_span"": 62, ""end_span"": 72, ""type"": ""Gene_or_gene_product""}, {""token"": ""- R2"", ""start_span"": 77, ""end_span"": 81, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell"", ""start_span"": 112, ""end_span"": 116, ""type"": ""Cell""}, {""token"": ""androgen"", ""start_span"": 148, ""end_span"": 156, ""type"": ""Chemical""}, {""token"": ""cells"", ""start_span"": 171, ""end_span"": 176, ""type"": ""Cell""}, {""token"": ""DU - 145"", ""start_span"": 179, ""end_span"": 187, ""type"": ""Cell""}, {""token"": ""PC - 3"", ""start_span"": 192, ""end_span"": 198, ""type"": ""Cell""}]"	test
G ( i) protein, phosphatidylinositol - 3 kinase ( PI3K), p38 mitogen - activated protein kinase ( MAPK), cytosolic phospholipase A ( 2) and urokinase type plasminogen activator ( uPA) are required for LPA - induced cells invasion.	phosphatidylinositol - 3 kinase,16,47,Gene_or_gene_product	PI3K,50,54,Gene_or_gene_product	p38 mitogen - activated protein kinase,57,95,Gene_or_gene_product	MAPK,98,102,Gene_or_gene_product	cytosolic,105,114,Organism_substance	urokinase type plasminogen activator,140,176,Gene_or_gene_product	uPA,179,182,Gene_or_gene_product	LPA,201,204,Chemical	cells,215,220,Cell	"[{""token"": ""phosphatidylinositol - 3 kinase"", ""start_span"": 16, ""end_span"": 47, ""type"": ""Gene_or_gene_product""}, {""token"": ""PI3K"", ""start_span"": 50, ""end_span"": 54, ""type"": ""Gene_or_gene_product""}, {""token"": ""p38 mitogen - activated protein kinase"", ""start_span"": 57, ""end_span"": 95, ""type"": ""Gene_or_gene_product""}, {""token"": ""MAPK"", ""start_span"": 98, ""end_span"": 102, ""type"": ""Gene_or_gene_product""}, {""token"": ""cytosolic"", ""start_span"": 105, ""end_span"": 114, ""type"": ""Organism_substance""}, {""token"": ""urokinase type plasminogen activator"", ""start_span"": 140, ""end_span"": 176, ""type"": ""Gene_or_gene_product""}, {""token"": ""uPA"", ""start_span"": 179, ""end_span"": 182, ""type"": ""Gene_or_gene_product""}, {""token"": ""LPA"", ""start_span"": 201, ""end_span"": 204, ""type"": ""Chemical""}, {""token"": ""cells"", ""start_span"": 215, ""end_span"": 220, ""type"": ""Cell""}]"	test
One such agent, 3 - bromopyruvate ( 3 - BrPA), a lactic acid analog, has been shown to inhibit both glycolytic and mitochondrial ATP production in rapidly growing cancers ( Ko et al., Cancer Letts., 173, 83 - 91, 2001), leave normal cells alone, and eradicate advanced cancers ( 19 of 19) in a rodent model ( Ko et al., Biochem. Biophys. Res. Commun., 324, 269 - 275, 2004).	3 - bromopyruvate,16,33,Chemical	3 - BrPA,36,44,Chemical	lactic acid analog,49,67,Chemical	mitochondrial,115,128,Cellular_component	ATP,129,132,Chemical	cancers,163,170,Cancer	cells,233,238,Cell	cancers,269,276,Cancer	rodent,294,300,Organism	"[{""token"": ""3 - bromopyruvate"", ""start_span"": 16, ""end_span"": 33, ""type"": ""Chemical""}, {""token"": ""3 - BrPA"", ""start_span"": 36, ""end_span"": 44, ""type"": ""Chemical""}, {""token"": ""lactic acid analog"", ""start_span"": 49, ""end_span"": 67, ""type"": ""Chemical""}, {""token"": ""mitochondrial"", ""start_span"": 115, ""end_span"": 128, ""type"": ""Cellular_component""}, {""token"": ""ATP"", ""start_span"": 129, ""end_span"": 132, ""type"": ""Chemical""}, {""token"": ""cancers"", ""start_span"": 163, ""end_span"": 170, ""type"": ""Cancer""}, {""token"": ""cells"", ""start_span"": 233, ""end_span"": 238, ""type"": ""Cell""}, {""token"": ""cancers"", ""start_span"": 269, ""end_span"": 276, ""type"": ""Cancer""}, {""token"": ""rodent"", ""start_span"": 294, ""end_span"": 300, ""type"": ""Organism""}]"	test
Furthermore, it was shown that thiol - containing antioxidants completely blocked MOG - induced mitochondrial DeltaPsim loss and subsequent cell apoptosis, while the inhibition of apoptosis by benzyloxy - carbonyl - Val - Ala - Asp - fluoromethylketone only partially attenuated mitochondrial DeltaPsim loss, indicating that MOG - induced redox imbalance is an early event upstream to mitochondrial DeltaPsim loss and caspase - 3 activation.	thiol,31,36,Chemical	MOG,82,85,Chemical	mitochondrial,96,109,Cellular_component	cell,140,144,Cell	benzyloxy - carbonyl - Val - Ala - Asp - fluoromethylketone,193,252,Chemical	mitochondrial,279,292,Cellular_component	MOG,325,328,Chemical	mitochondrial,385,398,Cellular_component	caspase - 3,418,429,Gene_or_gene_product	"[{""token"": ""thiol"", ""start_span"": 31, ""end_span"": 36, ""type"": ""Chemical""}, {""token"": ""MOG"", ""start_span"": 82, ""end_span"": 85, ""type"": ""Chemical""}, {""token"": ""mitochondrial"", ""start_span"": 96, ""end_span"": 109, ""type"": ""Cellular_component""}, {""token"": ""cell"", ""start_span"": 140, ""end_span"": 144, ""type"": ""Cell""}, {""token"": ""benzyloxy - carbonyl - Val - Ala - Asp - fluoromethylketone"", ""start_span"": 193, ""end_span"": 252, ""type"": ""Chemical""}, {""token"": ""mitochondrial"", ""start_span"": 279, ""end_span"": 292, ""type"": ""Cellular_component""}, {""token"": ""MOG"", ""start_span"": 325, ""end_span"": 328, ""type"": ""Chemical""}, {""token"": ""mitochondrial"", ""start_span"": 385, ""end_span"": 398, ""type"": ""Cellular_component""}, {""token"": ""caspase - 3"", ""start_span"": 418, ""end_span"": 429, ""type"": ""Gene_or_gene_product""}]"	test
Consistently, it was found that MOG rapidly decreased the intracellular glutathione ( GSH) content in a dose - dependent manner and the significance of GSH depletion in MOG - induced apoptosis was further supported by the protective effects of tert - butylhydroquinone ( tBHQ) and the facilitative effects of DL - buthionine ( S, R) - sulfoximine ( BSO).	MOG,32,35,Chemical	intracellular,58,71,Immaterial_anatomical_entity	glutathione,72,83,Chemical	GSH,86,89,Chemical	GSH,152,155,Chemical	MOG,169,172,Chemical	tert - butylhydroquinone,244,268,Chemical	tBHQ,271,275,Chemical	BSO,349,352,Chemical	"[{""token"": ""MOG"", ""start_span"": 32, ""end_span"": 35, ""type"": ""Chemical""}, {""token"": ""intracellular"", ""start_span"": 58, ""end_span"": 71, ""type"": ""Immaterial_anatomical_entity""}, {""token"": ""glutathione"", ""start_span"": 72, ""end_span"": 83, ""type"": ""Chemical""}, {""token"": ""GSH"", ""start_span"": 86, ""end_span"": 89, ""type"": ""Chemical""}, {""token"": ""GSH"", ""start_span"": 152, ""end_span"": 155, ""type"": ""Chemical""}, {""token"": ""MOG"", ""start_span"": 169, ""end_span"": 172, ""type"": ""Chemical""}, {""token"": ""tert - butylhydroquinone"", ""start_span"": 244, ""end_span"": 268, ""type"": ""Chemical""}, {""token"": ""tBHQ"", ""start_span"": 271, ""end_span"": 275, ""type"": ""Chemical""}, {""token"": ""BSO"", ""start_span"": 349, ""end_span"": 352, ""type"": ""Chemical""}]"	test
Clinical studies have shown elevated serum IL - 6 concentrations in patients with endometrial cancer, non - small cell lung carcinoma, colorectal cancer, renal cell carcinoma, breast and ovarian cancer.	serum,37,42,Organism_substance	IL - 6,43,49,Gene_or_gene_product	patients,68,76,Organism	endometrial cancer,82,100,Cancer	non - small cell lung carcinoma,102,133,Cancer	colorectal cancer,135,152,Cancer	renal cell carcinoma,154,174,Cancer	breast,176,182,Cancer	ovarian cancer,187,201,Cancer	"[{""token"": ""serum"", ""start_span"": 37, ""end_span"": 42, ""type"": ""Organism_substance""}, {""token"": ""IL - 6"", ""start_span"": 43, ""end_span"": 49, ""type"": ""Gene_or_gene_product""}, {""token"": ""patients"", ""start_span"": 68, ""end_span"": 76, ""type"": ""Organism""}, {""token"": ""endometrial cancer"", ""start_span"": 82, ""end_span"": 100, ""type"": ""Cancer""}, {""token"": ""non - small cell lung carcinoma"", ""start_span"": 102, ""end_span"": 133, ""type"": ""Cancer""}, {""token"": ""colorectal cancer"", ""start_span"": 135, ""end_span"": 152, ""type"": ""Cancer""}, {""token"": ""renal cell carcinoma"", ""start_span"": 154, ""end_span"": 174, ""type"": ""Cancer""}, {""token"": ""breast"", ""start_span"": 176, ""end_span"": 182, ""type"": ""Cancer""}, {""token"": ""ovarian cancer"", ""start_span"": 187, ""end_span"": 201, ""type"": ""Cancer""}]"	test
Enhancement of docetaxel - induced cytotoxicity and apoptosis by all - trans retinoic acid ( ATRA) through downregulation of survivin ( BIRC5), MCL - 1 and LTbeta - R in hormone - and drug resistant prostate cancer cell line, DU - 145.	docetaxel,15,24,Chemical	all - trans retinoic acid,65,90,Chemical	ATRA,93,97,Chemical	survivin,125,133,Gene_or_gene_product	BIRC5,136,141,Gene_or_gene_product	MCL - 1,144,151,Gene_or_gene_product	LTbeta - R,156,166,Gene_or_gene_product	prostate cancer cell line,199,224,Cell	DU - 145,226,234,Cell	"[{""token"": ""docetaxel"", ""start_span"": 15, ""end_span"": 24, ""type"": ""Chemical""}, {""token"": ""all - trans retinoic acid"", ""start_span"": 65, ""end_span"": 90, ""type"": ""Chemical""}, {""token"": ""ATRA"", ""start_span"": 93, ""end_span"": 97, ""type"": ""Chemical""}, {""token"": ""survivin"", ""start_span"": 125, ""end_span"": 133, ""type"": ""Gene_or_gene_product""}, {""token"": ""BIRC5"", ""start_span"": 136, ""end_span"": 141, ""type"": ""Gene_or_gene_product""}, {""token"": ""MCL - 1"", ""start_span"": 144, ""end_span"": 151, ""type"": ""Gene_or_gene_product""}, {""token"": ""LTbeta - R"", ""start_span"": 156, ""end_span"": 166, ""type"": ""Gene_or_gene_product""}, {""token"": ""prostate cancer cell line"", ""start_span"": 199, ""end_span"": 224, ""type"": ""Cell""}, {""token"": ""DU - 145"", ""start_span"": 226, ""end_span"": 234, ""type"": ""Cell""}]"	test
We have found out that docetaxel - ATRA combination significantly downregulates survivin ( BIRC5), myeloid cell leukemia - 1 ( MCL - 1) and lymphotoxin beta - receptor ( LTbetaR) genes, which all three have pivotal roles in regulation of apoptosis and cell cycle progression.	docetaxel,23,32,Chemical	ATRA,35,39,Chemical	survivin,80,88,Gene_or_gene_product	BIRC5,91,96,Gene_or_gene_product	myeloid cell leukemia - 1,99,124,Gene_or_gene_product	MCL - 1,127,134,Gene_or_gene_product	lymphotoxin beta - receptor,140,167,Gene_or_gene_product	LTbetaR,170,177,Gene_or_gene_product	cell,252,256,Cell	"[{""token"": ""docetaxel"", ""start_span"": 23, ""end_span"": 32, ""type"": ""Chemical""}, {""token"": ""ATRA"", ""start_span"": 35, ""end_span"": 39, ""type"": ""Chemical""}, {""token"": ""survivin"", ""start_span"": 80, ""end_span"": 88, ""type"": ""Gene_or_gene_product""}, {""token"": ""BIRC5"", ""start_span"": 91, ""end_span"": 96, ""type"": ""Gene_or_gene_product""}, {""token"": ""myeloid cell leukemia - 1"", ""start_span"": 99, ""end_span"": 124, ""type"": ""Gene_or_gene_product""}, {""token"": ""MCL - 1"", ""start_span"": 127, ""end_span"": 134, ""type"": ""Gene_or_gene_product""}, {""token"": ""lymphotoxin beta - receptor"", ""start_span"": 140, ""end_span"": 167, ""type"": ""Gene_or_gene_product""}, {""token"": ""LTbetaR"", ""start_span"": 170, ""end_span"": 177, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell"", ""start_span"": 252, ""end_span"": 256, ""type"": ""Cell""}]"	test
We show mutation of S727 to the phosphomimetic residue Glu, and inactivation of Y705 ( Y705F / S727E) resulted in a remarkable growth advantage in low - serum, enhanced anchorage - independent growth in soft agar, and increased tumorigenicity in nonobese diabetic / severe combined immunodeficient ( NOD / SCID) mice, possibly by direct activation of downstream proto - oncogenes c - myc, mcl - 1, and survivin.	S727,20,24,Amino_acid	Glu,55,58,Amino_acid	Y705,80,84,Amino_acid	Y705F,87,92,Amino_acid	S727E,95,100,Amino_acid	serum,153,158,Organism_substance	c - myc,380,387,Gene_or_gene_product	mcl - 1,389,396,Gene_or_gene_product	survivin,402,410,Gene_or_gene_product	"[{""token"": ""S727"", ""start_span"": 20, ""end_span"": 24, ""type"": ""Amino_acid""}, {""token"": ""Glu"", ""start_span"": 55, ""end_span"": 58, ""type"": ""Amino_acid""}, {""token"": ""Y705"", ""start_span"": 80, ""end_span"": 84, ""type"": ""Amino_acid""}, {""token"": ""Y705F"", ""start_span"": 87, ""end_span"": 92, ""type"": ""Amino_acid""}, {""token"": ""S727E"", ""start_span"": 95, ""end_span"": 100, ""type"": ""Amino_acid""}, {""token"": ""serum"", ""start_span"": 153, ""end_span"": 158, ""type"": ""Organism_substance""}, {""token"": ""c - myc"", ""start_span"": 380, ""end_span"": 387, ""type"": ""Gene_or_gene_product""}, {""token"": ""mcl - 1"", ""start_span"": 389, ""end_span"": 396, ""type"": ""Gene_or_gene_product""}, {""token"": ""survivin"", ""start_span"": 402, ""end_span"": 410, ""type"": ""Gene_or_gene_product""}]"	test
In conclusion, CXCR4 expression is associated with gastric cancer cell migration in vitro, and strong expression of CXCR4 by gastric cancer cells is significantly associated with lymphatic metastasis in patients with gastric cancer, suggesting that CXCR4 plays an important role during gastric cancer progression.	CXCR4,15,20,Gene_or_gene_product	gastric cancer cell,51,70,Cell	CXCR4,116,121,Gene_or_gene_product	gastric cancer cells,125,145,Cell	lymphatic,179,188,Organ	patients,203,211,Organism	gastric cancer,217,231,Cancer	CXCR4,249,254,Gene_or_gene_product	gastric cancer,286,300,Cancer	"[{""token"": ""CXCR4"", ""start_span"": 15, ""end_span"": 20, ""type"": ""Gene_or_gene_product""}, {""token"": ""gastric cancer cell"", ""start_span"": 51, ""end_span"": 70, ""type"": ""Cell""}, {""token"": ""CXCR4"", ""start_span"": 116, ""end_span"": 121, ""type"": ""Gene_or_gene_product""}, {""token"": ""gastric cancer cells"", ""start_span"": 125, ""end_span"": 145, ""type"": ""Cell""}, {""token"": ""lymphatic"", ""start_span"": 179, ""end_span"": 188, ""type"": ""Organ""}, {""token"": ""patients"", ""start_span"": 203, ""end_span"": 211, ""type"": ""Organism""}, {""token"": ""gastric cancer"", ""start_span"": 217, ""end_span"": 231, ""type"": ""Cancer""}, {""token"": ""CXCR4"", ""start_span"": 249, ""end_span"": 254, ""type"": ""Gene_or_gene_product""}, {""token"": ""gastric cancer"", ""start_span"": 286, ""end_span"": 300, ""type"": ""Cancer""}]"	test
Based on the observation that netrin - 1, the anti - apoptotic ligand for the dependence receptors DCC and UNC5H is up - regulated in colonic crypts in response to NF - kappaB, we show here that colorectal cancers from inflammatory bowel diseases patients have selected up - regulation of netrin - 1.	netrin - 1,30,40,Gene_or_gene_product	DCC,99,102,Gene_or_gene_product	UNC5H,107,112,Gene_or_gene_product	colonic crypts,134,148,Organ	NF - kappaB,164,175,Gene_or_gene_product	colorectal cancers,195,213,Cancer	bowel,232,237,Organ	patients,247,255,Organism	netrin - 1,289,299,Gene_or_gene_product	"[{""token"": ""netrin - 1"", ""start_span"": 30, ""end_span"": 40, ""type"": ""Gene_or_gene_product""}, {""token"": ""DCC"", ""start_span"": 99, ""end_span"": 102, ""type"": ""Gene_or_gene_product""}, {""token"": ""UNC5H"", ""start_span"": 107, ""end_span"": 112, ""type"": ""Gene_or_gene_product""}, {""token"": ""colonic crypts"", ""start_span"": 134, ""end_span"": 148, ""type"": ""Organ""}, {""token"": ""NF - kappaB"", ""start_span"": 164, ""end_span"": 175, ""type"": ""Gene_or_gene_product""}, {""token"": ""colorectal cancers"", ""start_span"": 195, ""end_span"": 213, ""type"": ""Cancer""}, {""token"": ""bowel"", ""start_span"": 232, ""end_span"": 237, ""type"": ""Organ""}, {""token"": ""patients"", ""start_span"": 247, ""end_span"": 255, ""type"": ""Organism""}, {""token"": ""netrin - 1"", ""start_span"": 289, ""end_span"": 299, ""type"": ""Gene_or_gene_product""}]"	test
In contrast, knockdown of Pbx1 did not impair bone marrow transformation by E2A / HLF or AML1 / ETO, suggesting that Pbx1 is specifically required for the maintenance of bone marrow transformation mediated by Evi - 1.	Pbx1,26,30,Gene_or_gene_product	bone marrow,46,57,Multi	E2A,76,79,Gene_or_gene_product	HLF,82,85,Gene_or_gene_product	AML1,89,93,Gene_or_gene_product	ETO,96,99,Gene_or_gene_product	Pbx1,117,121,Gene_or_gene_product	bone marrow,170,181,Multi	Evi - 1,209,216,Gene_or_gene_product	"[{""token"": ""Pbx1"", ""start_span"": 26, ""end_span"": 30, ""type"": ""Gene_or_gene_product""}, {""token"": ""bone marrow"", ""start_span"": 46, ""end_span"": 57, ""type"": ""Multi""}, {""token"": ""E2A"", ""start_span"": 76, ""end_span"": 79, ""type"": ""Gene_or_gene_product""}, {""token"": ""HLF"", ""start_span"": 82, ""end_span"": 85, ""type"": ""Gene_or_gene_product""}, {""token"": ""AML1"", ""start_span"": 89, ""end_span"": 93, ""type"": ""Gene_or_gene_product""}, {""token"": ""ETO"", ""start_span"": 96, ""end_span"": 99, ""type"": ""Gene_or_gene_product""}, {""token"": ""Pbx1"", ""start_span"": 117, ""end_span"": 121, ""type"": ""Gene_or_gene_product""}, {""token"": ""bone marrow"", ""start_span"": 170, ""end_span"": 181, ""type"": ""Multi""}, {""token"": ""Evi - 1"", ""start_span"": 209, ""end_span"": 216, ""type"": ""Gene_or_gene_product""}]"	test
Here we found that inactivation of the Notch effectors Hes1, Hes3 and Hes5, but not Hes1 alone, led to reduced cell proliferation, increased secretory cell formation and altered intestinal structures in adult mice.	Notch,39,44,Gene_or_gene_product	Hes1,55,59,Gene_or_gene_product	Hes3,61,65,Gene_or_gene_product	Hes5,70,74,Gene_or_gene_product	Hes1,84,88,Gene_or_gene_product	cell,111,115,Cell	secretory cell,141,155,Cell	intestinal structures,178,199,Tissue	adult mice,203,213,Organism	"[{""token"": ""Notch"", ""start_span"": 39, ""end_span"": 44, ""type"": ""Gene_or_gene_product""}, {""token"": ""Hes1"", ""start_span"": 55, ""end_span"": 59, ""type"": ""Gene_or_gene_product""}, {""token"": ""Hes3"", ""start_span"": 61, ""end_span"": 65, ""type"": ""Gene_or_gene_product""}, {""token"": ""Hes5"", ""start_span"": 70, ""end_span"": 74, ""type"": ""Gene_or_gene_product""}, {""token"": ""Hes1"", ""start_span"": 84, ""end_span"": 88, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell"", ""start_span"": 111, ""end_span"": 115, ""type"": ""Cell""}, {""token"": ""secretory cell"", ""start_span"": 141, ""end_span"": 155, ""type"": ""Cell""}, {""token"": ""intestinal structures"", ""start_span"": 178, ""end_span"": 199, ""type"": ""Tissue""}, {""token"": ""adult mice"", ""start_span"": 203, ""end_span"": 213, ""type"": ""Organism""}]"	test
Coexpression of the human Met receptor and its ligand, hepatocyte growth factor / scatter factor ( HGF / SF), in NIH 3T3 fibroblasts causes the cells to become tumorigenic in nude mice.	human,20,25,Organism	Met,26,29,Gene_or_gene_product	hepatocyte growth factor,55,79,Gene_or_gene_product	scatter factor,82,96,Gene_or_gene_product	HGF,99,102,Gene_or_gene_product	SF,105,107,Gene_or_gene_product	NIH 3T3 fibroblasts,113,132,Cell	cells,144,149,Cell	nude mice,175,184,Organism	"[{""token"": ""human"", ""start_span"": 20, ""end_span"": 25, ""type"": ""Organism""}, {""token"": ""Met"", ""start_span"": 26, ""end_span"": 29, ""type"": ""Gene_or_gene_product""}, {""token"": ""hepatocyte growth factor"", ""start_span"": 55, ""end_span"": 79, ""type"": ""Gene_or_gene_product""}, {""token"": ""scatter factor"", ""start_span"": 82, ""end_span"": 96, ""type"": ""Gene_or_gene_product""}, {""token"": ""HGF"", ""start_span"": 99, ""end_span"": 102, ""type"": ""Gene_or_gene_product""}, {""token"": ""SF"", ""start_span"": 105, ""end_span"": 107, ""type"": ""Gene_or_gene_product""}, {""token"": ""NIH 3T3 fibroblasts"", ""start_span"": 113, ""end_span"": 132, ""type"": ""Cell""}, {""token"": ""cells"", ""start_span"": 144, ""end_span"": 149, ""type"": ""Cell""}, {""token"": ""nude mice"", ""start_span"": 175, ""end_span"": 184, ""type"": ""Organism""}]"	test
However, E mu - directed coexpression of cyclin D1 and N - MYC or L - MYC in double transgenic mice reveals a strong cooperative effect between MYC and cyclin D1 provoking the rapid development of clonal pre - B and B - cell lymphomas.	E mu,9,13,Gene_or_gene_product	cyclin D1,41,50,Gene_or_gene_product	N - MYC,55,62,Gene_or_gene_product	L - MYC,66,73,Gene_or_gene_product	transgenic mice,84,99,Organism	MYC,144,147,Gene_or_gene_product	cyclin D1,152,161,Gene_or_gene_product	pre - B,204,211,Cancer	B - cell lymphomas,216,234,Cancer	"[{""token"": ""E mu"", ""start_span"": 9, ""end_span"": 13, ""type"": ""Gene_or_gene_product""}, {""token"": ""cyclin D1"", ""start_span"": 41, ""end_span"": 50, ""type"": ""Gene_or_gene_product""}, {""token"": ""N - MYC"", ""start_span"": 55, ""end_span"": 62, ""type"": ""Gene_or_gene_product""}, {""token"": ""L - MYC"", ""start_span"": 66, ""end_span"": 73, ""type"": ""Gene_or_gene_product""}, {""token"": ""transgenic mice"", ""start_span"": 84, ""end_span"": 99, ""type"": ""Organism""}, {""token"": ""MYC"", ""start_span"": 144, ""end_span"": 147, ""type"": ""Gene_or_gene_product""}, {""token"": ""cyclin D1"", ""start_span"": 152, ""end_span"": 161, ""type"": ""Gene_or_gene_product""}, {""token"": ""pre - B"", ""start_span"": 204, ""end_span"": 211, ""type"": ""Cancer""}, {""token"": ""B - cell lymphomas"", ""start_span"": 216, ""end_span"": 234, ""type"": ""Cancer""}]"	test
Nursing actions to support the humoral and cell - mediated immune system of the burned patient include providing nutritional support to maintain serum protein levels at optimal levels; measures to decrease edema and promote angiogenesis in areas of partial - thickness injury; meticulous treatment of the wound to prevent infection and promote healing; monitoring of antibiotic use; conservative use of invasive techniques, including intubation and vascular access devices; maintenance of fluid and electrolyte balance and body temperature; and energy conservation measures.	cell,43,47,Cell	immune system,59,72,Anatomical_system	patient,87,94,Organism	serum,145,150,Organism_substance	edema,206,211,Pathological_formation	wound,305,310,Pathological_formation	vascular,449,457,Multi	fluid,489,494,Organism_substance	body,523,527,Organism_subdivision	"[{""token"": ""cell"", ""start_span"": 43, ""end_span"": 47, ""type"": ""Cell""}, {""token"": ""immune system"", ""start_span"": 59, ""end_span"": 72, ""type"": ""Anatomical_system""}, {""token"": ""patient"", ""start_span"": 87, ""end_span"": 94, ""type"": ""Organism""}, {""token"": ""serum"", ""start_span"": 145, ""end_span"": 150, ""type"": ""Organism_substance""}, {""token"": ""edema"", ""start_span"": 206, ""end_span"": 211, ""type"": ""Pathological_formation""}, {""token"": ""wound"", ""start_span"": 305, ""end_span"": 310, ""type"": ""Pathological_formation""}, {""token"": ""vascular"", ""start_span"": 449, ""end_span"": 457, ""type"": ""Multi""}, {""token"": ""fluid"", ""start_span"": 489, ""end_span"": 494, ""type"": ""Organism_substance""}, {""token"": ""body"", ""start_span"": 523, ""end_span"": 527, ""type"": ""Organism_subdivision""}]"	test
Anti - Fas treatment of these cells caused a significant decrease in p120 - GAP levels, ERK - 1 levels, and phosphorylation, as well as Grb2 - Sosl and MEK - 1 - ERK - 1 association.	Fas,7,10,Gene_or_gene_product	cells,30,35,Cell	p120,69,73,Gene_or_gene_product	GAP,76,79,Gene_or_gene_product	ERK - 1,88,95,Gene_or_gene_product	Grb2,136,140,Gene_or_gene_product	Sosl,143,147,Gene_or_gene_product	MEK - 1,152,159,Gene_or_gene_product	ERK - 1,162,169,Gene_or_gene_product	"[{""token"": ""Fas"", ""start_span"": 7, ""end_span"": 10, ""type"": ""Gene_or_gene_product""}, {""token"": ""cells"", ""start_span"": 30, ""end_span"": 35, ""type"": ""Cell""}, {""token"": ""p120"", ""start_span"": 69, ""end_span"": 73, ""type"": ""Gene_or_gene_product""}, {""token"": ""GAP"", ""start_span"": 76, ""end_span"": 79, ""type"": ""Gene_or_gene_product""}, {""token"": ""ERK - 1"", ""start_span"": 88, ""end_span"": 95, ""type"": ""Gene_or_gene_product""}, {""token"": ""Grb2"", ""start_span"": 136, ""end_span"": 140, ""type"": ""Gene_or_gene_product""}, {""token"": ""Sosl"", ""start_span"": 143, ""end_span"": 147, ""type"": ""Gene_or_gene_product""}, {""token"": ""MEK - 1"", ""start_span"": 152, ""end_span"": 159, ""type"": ""Gene_or_gene_product""}, {""token"": ""ERK - 1"", ""start_span"": 162, ""end_span"": 169, ""type"": ""Gene_or_gene_product""}]"	test
MATERIALS AND METHODS: Urine from 81 patients with RDEB ( 39 patients), junctional epidermolysis bullosa ( JEB; 12 patients), and epidermolysis bullosa simplex ( EBS; 30 patients), as well as unaffected family members of RDEB patients ( 33 patients), was tested for the presence of basic fibroblast growth factor ( bFGF) using a sensitive radioimmunoassay.	Urine,23,28,Organism_substance	patients,37,45,Organism	patients,61,69,Organism	patients,115,123,Organism	patients,170,178,Organism	patients,226,234,Organism	patients,240,248,Organism	basic fibroblast growth factor,282,312,Gene_or_gene_product	bFGF,315,319,Gene_or_gene_product	"[{""token"": ""Urine"", ""start_span"": 23, ""end_span"": 28, ""type"": ""Organism_substance""}, {""token"": ""patients"", ""start_span"": 37, ""end_span"": 45, ""type"": ""Organism""}, {""token"": ""patients"", ""start_span"": 61, ""end_span"": 69, ""type"": ""Organism""}, {""token"": ""patients"", ""start_span"": 115, ""end_span"": 123, ""type"": ""Organism""}, {""token"": ""patients"", ""start_span"": 170, ""end_span"": 178, ""type"": ""Organism""}, {""token"": ""patients"", ""start_span"": 226, ""end_span"": 234, ""type"": ""Organism""}, {""token"": ""patients"", ""start_span"": 240, ""end_span"": 248, ""type"": ""Organism""}, {""token"": ""basic fibroblast growth factor"", ""start_span"": 282, ""end_span"": 312, ""type"": ""Gene_or_gene_product""}, {""token"": ""bFGF"", ""start_span"": 315, ""end_span"": 319, ""type"": ""Gene_or_gene_product""}]"	test
